https://novapharmanews.com/us/news/adial-pharmaceuticals-cdo-adds-equity-after-azora-merger 2026-07-06T17:24:09.958Z weekly 0.7 https://novapharmanews.com/eu/news/eu-pharma-package-exclusivity-timelines-what-innovators-can-do-now 2026-07-05T04:29:39.447Z weekly 0.7 https://novapharmanews.com/us/news/biotechs-coming-of-age-ai-capital-efficiency-china 2026-07-06T16:48:49.707Z weekly 0.7 https://novapharmanews.com/us/news/edgewise-therapeutics-edg-7500-phase-2-cirrus-hcm-test 2026-07-06T16:48:49.429Z weekly 0.7 https://novapharmanews.com/us/news/celiac-disease-new-era-therapeutic-innovation 2026-07-06T16:48:45.762Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-otc-rextovy-broadening-naloxone-access-opioid-overdose 2026-07-06T16:48:41.716Z weekly 0.7 https://novapharmanews.com/us/news/neumora-navacaprant-fails-phase-3-engene-cuts-50-percent-of-staff 2026-07-06T13:10:41.448Z weekly 0.7 https://novapharmanews.com/us/news/global-hematology-trials-patient-centered-regionally-relevant 2026-07-06T16:48:49.206Z weekly 0.7 https://novapharmanews.com/us/news/lilly-early-jak-data-myelofibrosis-competes-with-jakafi 2026-07-06T16:48:46.044Z weekly 0.7 https://novapharmanews.com/us/news/fda-authorizes-emergency-pet-treatment-new-world-screwworm 2026-07-06T13:21:02.083Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-sharing-potential-nda-patent-information 2026-07-06T18:15:40.738Z weekly 0.7 https://novapharmanews.com/us/news/hillhurst-bio-doses-first-subject-phase-2a-hbi-002-parkinsons-trial 2026-07-06T10:06:13.061Z weekly 0.7 https://novapharmanews.com/us/news/fda-expands-tzield-pediatric-stage-3-type-1-diabetes 2026-07-06T17:29:22.318Z weekly 0.7 https://novapharmanews.com/eu/news/ema-board-backs-ebola-response-flags-2025-annual-report-june-2026-meeting 2026-07-06T14:23:17.818Z weekly 0.7 https://novapharmanews.com/us/news/medicare-price-rule-keytruda-opdivo-subcutaneous-launches 2026-07-06T17:48:58.290Z weekly 0.7 https://novapharmanews.com/eu/news/ema-tightens-liver-safety-checks-tavneos-avacopan 2026-07-06T18:12:38.956Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-capivasertib-pten-deficient-prostate-cancer 2026-07-06T15:07:39.586Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-belzutifan-plus-pembrolizumab-adjuvant-rcc 2026-07-06T14:24:45.219Z weekly 0.7 https://novapharmanews.com/apac/news/piyush-goyal-invites-global-pharma-firms-to-partner-with-india 2026-07-06T11:08:06.674Z weekly 0.7 https://novapharmanews.com/us/news/prescription-drug-freight-fraud-june-2026-report 2026-07-05T02:02:35.327Z weekly 0.7 https://novapharmanews.com/us/news/planning-a-successful-pivot-from-lab-to-clinic-practical-career-map 2026-07-05T17:39:02.130Z weekly 0.7 https://novapharmanews.com/eu/news/fda-approves-capivasertib-abiraterone-prednisone-pten-deficient-mhspc 2026-07-05T00:11:50.938Z weekly 0.7 https://novapharmanews.com/eu/news/china-big-pharma-essential-rd-partner 2026-07-06T14:12:47.224Z weekly 0.7 https://novapharmanews.com/us/news/hfma-conference-affordability-friction-high-hospital-costs 2026-07-06T01:46:21.110Z weekly 0.7 https://novapharmanews.com/us/news/fda-draft-guidance-payor-communications-rules 2026-07-06T08:57:00.270Z weekly 0.7 https://novapharmanews.com/eu/news/mhra-targets-medicine-safety-with-new-ai-sandbox 2026-07-06T01:09:11.524Z weekly 0.7 https://novapharmanews.com/eu/news/biocryst-new-orladeyo-data-real-world-evidence-hae 2026-07-06T10:09:49.323Z weekly 0.7 https://novapharmanews.com/eu/news/ema-researchers-map-ai-research-priorities-across-the-medicines-lifecycle 2026-07-06T08:30:16.203Z weekly 0.7 https://novapharmanews.com/us/news/alembic-tentative-fda-approval-generic-larotrectinib-capsules 2026-07-06T18:34:58.265Z weekly 0.7 https://novapharmanews.com/eu/news/truqap-us-approval-pten-deficient-metastatic-prostate-cancer 2026-07-03T00:51:07.266Z weekly 0.7 https://novapharmanews.com/us/news/fda-clears-first-otc-cgm-for-children-dexcom-stelo 2026-07-06T15:48:02.637Z weekly 0.7 https://novapharmanews.com/us/news/fda-priority-review-belzutifan-pembrolizumab-adjuvant-renal-cell-carcinoma 2026-07-06T13:35:28.362Z weekly 0.7 https://novapharmanews.com/us/news/chile-warning-labels-on-food-new-evidence-efficacy-obesity-risk 2026-07-06T14:39:47.087Z weekly 0.7 https://novapharmanews.com/eu/news/duty-of-care-oncology-conferences-planetary-health-research 2026-07-03T22:20:40.310Z weekly 0.7 https://novapharmanews.com/us/news/socioeconomic-status-shapes-childrens-brain-development-study-finds 2026-07-05T17:33:05.695Z weekly 0.7 https://novapharmanews.com/eu/news/synthetic-real-world-data-oncology-trial-decision-making 2026-07-06T10:01:55.649Z weekly 0.7 https://novapharmanews.com/us/news/fda-bemotrizinol-sunscreen-regulatory-update 2026-07-06T07:22:16.537Z weekly 0.7 https://novapharmanews.com/us/news/biotech-coming-of-age-market-analysis 2026-07-06T17:27:41.421Z weekly 0.7 https://novapharmanews.com/eu/news/ema-approved-104-human-medicines-in-2025-what-changed 2026-07-06T18:20:37.784Z weekly 0.7 https://novapharmanews.com/eu/news/ema-post-authorisation-guidance-evidence-gaps-10-years 2026-07-06T12:58:32.209Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-vepdegestrant-veppanu-esr1-mutated-breast-cancer 2026-07-06T11:15:27.523Z weekly 0.7 https://novapharmanews.com/us/news/cdc-data-alcohol-use-during-pregnancy-rising-again 2026-07-06T13:49:44.426Z weekly 0.7 https://novapharmanews.com/us/news/sensorion-pivots-to-sens-601-after-regenerons-otof-hearing-loss-advance 2026-07-06T02:09:23.667Z weekly 0.7 https://novapharmanews.com/us/news/takeda-tyk2-drug-tops-bristol-myers-sotyktu-psoriasis-head-to-head-test 2026-07-06T14:59:43.085Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-human-factors-information-marketing-submissions 2026-07-06T13:44:57.842Z weekly 0.7 https://novapharmanews.com/us/news/fda-authorizes-generic-nitenpyram-new-world-screwworm-pets 2026-07-06T11:59:59.591Z weekly 0.7 https://novapharmanews.com/us/news/sls-stock-jumps-biotech-momentum-sellas-gains-2510-percent 2026-07-04T10:15:31.806Z weekly 0.7 https://novapharmanews.com/us/news/hhs-responds-coolly-to-alcohol-risk-paper-amid-cancer-warning-debate 2026-07-06T18:23:23.972Z weekly 0.7 https://novapharmanews.com/apac/news/blood-pressure-ischemic-stroke-risk-dementia-nationwide-cohort 2026-07-06T11:08:09.495Z weekly 0.7 https://novapharmanews.com/us/news/sepsis-ai-algorithms-need-real-time-data-not-hindsight 2026-07-06T01:31:04.312Z weekly 0.7 https://novapharmanews.com/eu/news/ema-approves-tx01-pip-unlocking-puma-pathway-theranexus-exeltis 2026-07-05T21:20:18.896Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-first-interchangeable-biosimilars-simponi-simponi-aria 2026-07-06T15:56:36.614Z weekly 0.7 https://novapharmanews.com/us/news/astrazeneca-obesity-push-ultrasound-genetic-medicine-125m 2026-07-06T03:05:11.883Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-backs-nerandomilast-for-ipf-and-ppf-in-eu 2026-07-06T18:02:43.948Z weekly 0.7 https://novapharmanews.com/us/news/fda-drug-approval-what-approval-means-for-pharma-marketing-bd 2026-07-06T03:17:44.568Z weekly 0.7 https://novapharmanews.com/apac/news/pmda-approves-enhertu-for-her2-low-breast-cancer-in-japan 2026-07-06T11:08:06.905Z weekly 0.7 https://novapharmanews.com/us/news/fda-salmonella-moringa-leaf-powder-recall-january-2026 2026-07-06T15:42:26.301Z weekly 0.7 https://novapharmanews.com/eu/news/krx-ir-reference-s896010510626060808350-scd-ndr-eng-jun-2026 2026-07-06T05:06:29.135Z weekly 0.7 https://novapharmanews.com/us/news/nektar-therapeutics-pipeline-update-rezpeg-amphotericin-b-uk-site-changes 2026-07-06T08:36:57.968Z weekly 0.7 https://novapharmanews.com/us/news/vanda-tradipitant-update-fda-re-review-dec-5-2025 2026-07-06T12:47:17.959Z weekly 0.7 https://novapharmanews.com/us/news/sanofi-pipeline-pdf-dupixent-lantus-2026-catalysts 2026-07-06T17:53:46.770Z weekly 0.7 https://novapharmanews.com/us/news/cardiff-oncology-pipeline-update-onvansertib-trials-fda-meeting-catalysts 2026-07-06T07:59:38.893Z weekly 0.7 https://novapharmanews.com/us/news/alnylam-pipeline-update-amvuttra-catalysts-outlook-profitability 2026-07-05T07:53:52.716Z weekly 0.7 https://novapharmanews.com/us/news/neurocrine-biosciences-pipeline-update-catalyst-watch 2026-07-06T17:23:54.351Z weekly 0.7 https://novapharmanews.com/us/news/arcus-biosciences-pipeline-catalyst-update-casdatifan-quemliclustat-domvanalimab 2026-07-05T16:18:30.742Z weekly 0.7 https://novapharmanews.com/us/news/syndax-pipeline-update-revuforj-niktimvo-catalysts 2026-07-06T16:20:09.838Z weekly 0.7 https://novapharmanews.com/us/news/tillomed-laboratories-pipeline-catalyst-update 2026-07-06T11:15:07.714Z weekly 0.7 https://novapharmanews.com/us/news/2m-gene-therapy-cures-financing-model 2026-07-06T16:48:49.535Z weekly 0.7 https://novapharmanews.com/apac/news/tga-australia-drug-approval-pharmaceutical 2026-07-06T17:21:31.841Z weekly 0.7 https://novapharmanews.com/us/news/precision-under-pressure-logistics-facts-nuclear-medicine-scalability 2026-07-05T12:48:42.682Z weekly 0.7 https://novapharmanews.com/us/news/innovation-alone-no-longer-enough-biopharma 2026-07-05T17:54:54.511Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-lumasiran-acute-hepatic-porphyria-2026 2026-07-06T17:26:18.534Z weekly 0.7 https://novapharmanews.com/eu/news/eu-secures-emergency-favipiravir-deliveries-hantavirus-response 2026-07-04T18:39:34.016Z weekly 0.7 https://novapharmanews.com/eu/news/eye-drugs-list-sodium-hyaluronate-tafluprost-tobramycin-uses 2026-07-06T00:37:13.557Z weekly 0.7 https://novapharmanews.com/apac/news/areas-with-risk-of-dengue-cdc-map-criteria-global-reach 2026-07-06T11:08:09.349Z weekly 0.7 https://novapharmanews.com/us/news/breast-cancer-statistics-worldwide-what-the-data-shows 2026-07-06T18:00:45.224Z weekly 0.7 https://novapharmanews.com/us/news/manufacturing-pipeline-approvals-evidence-confirms 2026-07-06T18:00:35.063Z weekly 0.7 https://novapharmanews.com/us/news/glp-1-usage-statistics-data-shows 2026-07-06T16:40:37.422Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-supply-wegovy-stabilizes-new-manufacturing-capacity 2026-07-06T16:55:43.161Z weekly 0.7 https://novapharmanews.com/us/news/biontech-first-patient-phase-1-pancreatic-cancer-mrna-vaccine-trial 2026-07-06T15:41:50.282Z weekly 0.7 https://novapharmanews.com/us/news/maritide-phase-2-obesity-data-20-percent-weight-loss-one-year 2026-07-06T17:04:49.826Z weekly 0.7 https://novapharmanews.com/us/news/gsk-blenrep-returns-us-market-fda-approves-resubmission 2026-07-06T15:53:19.658Z weekly 0.7 https://novapharmanews.com/us/news/moderna-mrna-1083-phase-3-flu-covid-immune-response 2026-07-06T17:21:42.100Z weekly 0.7 https://novapharmanews.com/us/news/danuglipron-phase-3-pfizer-phase-2b-obesity-trial 2026-07-06T17:07:27.113Z weekly 0.7 https://novapharmanews.com/us/news/biogen-eisai-expand-leqembi-access-subcutaneous-maintenance-dosing 2026-07-05T22:59:17.479Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-vyloy-her2-negative-gastric-gej-cancer 2026-07-06T18:17:01.697Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-supply-of-wegovy-stabilizes-as-fda-shortage-ends 2026-07-06T16:55:43.068Z weekly 0.7 https://novapharmanews.com/us/news/jj-reports-positive-phase-3-tremfya-data-ulcerative-colitis 2026-07-05T00:41:31.868Z weekly 0.7 https://novapharmanews.com/us/news/sanofi-completes-inhibrx-acquisition-for-1-7b 2026-07-06T18:16:01.052Z weekly 0.7 https://novapharmanews.com/us/news/mari-tide-phase-2-amgen-reports-up-to-20-percent-weight-loss-at-one-year 2026-07-06T17:04:13.013Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-dupixent-for-copd-eosinophilic-phenotype 2026-07-06T16:19:18.105Z weekly 0.7 https://novapharmanews.com/us/news/gsk-blenrep-fda-approval-relapsed-multiple-myeloma 2026-07-06T16:58:34.240Z weekly 0.7 https://novapharmanews.com/us/news/merck-harpoon-therapeutics-acquisition-oncology-pipeline 2026-07-06T15:54:04.331Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-danuglipron-phase-2b-obesity-endpoint 2026-07-06T15:52:16.808Z weekly 0.7 https://novapharmanews.com/us/news/roche-positive-phase-3-trontinemab-alzheimers-disease 2026-07-06T18:06:10.731Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-merck 2026-07-06T12:33:37.380Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-mercks-keytruda-adjuvant-nsclc-treatment 2026-07-05T13:34:08.680Z weekly 0.7 https://novapharmanews.com/us/news/eli-lilly-donanemab-wins-fda-approval-early-alzheimers-disease 2026-07-06T16:10:38.139Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-merck-catalyst 2026-07-06T12:59:10.060Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-early-stage-lung-cancer 2026-07-06T14:29:02.539Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-merck-investor-watch 2026-07-06T06:28:42.534Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-cagrisema-phase-3-obesity-results-catalyst 2026-07-06T17:06:49.743Z weekly 0.7 https://novapharmanews.com/apac/news/fosun-pharma-aribio-option-agreement 2026-07-06T11:08:13.376Z weekly 0.7 https://novapharmanews.com/us/news/triple-hormone-receptor-agonist-retatrutide-obesity-phase-3-results 2026-07-06T13:16:14.600Z weekly 0.7 https://novapharmanews.com/us/news/fda-industry-friendly-gene-therapy-guidance-bd 2026-07-06T18:15:30.584Z weekly 0.7 https://novapharmanews.com/us/news/johnson-and-johnson-asco-2026-data-adds-depth-to-jnj-valuation-story 2026-07-06T10:36:50.891Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-berobenatide-obesity-drug-vesper-3-data 2026-07-06T12:44:48.254Z weekly 0.7 https://novapharmanews.com/us/news/puma-biotechnology-inducement-awards-nasdaq-5635c4-june-2026 2026-07-05T15:01:01.047Z weekly 0.7 https://novapharmanews.com/eu/news/world-lightproof-bottle-opaque-liners-market-pharma-growth-2035 2026-07-06T18:34:01.365Z weekly 0.7 https://novapharmanews.com/apac/news/pmda-regulatory-updates-orphan-drug-portal-asean-symposium 2026-07-06T14:55:30.502Z weekly 0.7 https://novapharmanews.com/eu/news/emea-2026-life-sciences-industry-cluster-report-market-analysis 2026-07-06T07:11:56.466Z weekly 0.7 https://novapharmanews.com/us/news/facet-life-sciences-appoints-frank-closurdo-vp-commercial-services 2026-07-03T09:36:26.804Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-berobenatide-monthly-obesity-drug-phase-2b-data 2026-07-06T13:53:38.838Z monthly 0.5 https://novapharmanews.com/us/news/listeria-outbreak-soft-cheese-fda-investigation 2026-07-06T17:07:26.130Z monthly 0.5 https://novapharmanews.com/us/news/cdc-ebola-outbreak-central-africa-20000-cases-2026 2026-07-06T13:31:02.365Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-china-fda-drug-approval-2026-pathways-timelines-impact 2026-07-06T17:00:34.260Z monthly 0.5 https://novapharmanews.com/eu/news/maersk-europe-market-update-june-2026-pharma-supply-chains 2026-07-06T12:01:35.933Z monthly 0.5 https://novapharmanews.com/eu/news/regulatory-round-up-2-february-2026 2026-07-06T13:13:55.269Z monthly 0.5 https://novapharmanews.com/us/news/fda-issues-june-2026-guidance-gene-therapy-payor-comms-cmc-flexibilities 2026-07-06T18:14:21.830Z monthly 0.5 https://novapharmanews.com/us/news/friday-five-asco-takeaways-ada-china-deals-clinical-trials 2026-07-05T20:14:59.255Z monthly 0.5 https://novapharmanews.com/us/news/pharmalittle-roche-blackmail-skinny-labels-supreme-court 2026-07-06T17:41:23.802Z monthly 0.5 https://novapharmanews.com/us/news/ebola-2026-us-response-travel-restrictions-debate 2026-07-03T18:22:55.006Z monthly 0.5 https://novapharmanews.com/us/news/senior-nih-official-pushes-maha-strategy-to-skeptical-ada-audience 2026-07-03T20:33:42.180Z monthly 0.5 https://novapharmanews.com/us/news/newer-glp-1s-pushback-research-cuts-protest 2026-07-06T18:29:05.949Z monthly 0.5 https://novapharmanews.com/us/news/abivax-colitis-drug-hits-goal-cancer-cases-rattle-investors 2026-07-05T18:52:41.128Z monthly 0.5 https://novapharmanews.com/us/news/supreme-court-sides-with-generic-drug-maker-icosapent-ethyl 2026-07-04T18:23:43.471Z monthly 0.5 https://novapharmanews.com/eu/news/baker-company-benelux-joins-europabio-cell-culture-lab-safety 2026-07-04T21:34:09.815Z monthly 0.5 https://novapharmanews.com/us/news/rx-rundown-pfizer-hikma-newlimit-drug-approvals-catalyst-tracker 2026-07-05T15:12:57.915Z monthly 0.5 https://novapharmanews.com/us/news/mira-pharmaceuticals-global-rights-mira-55-skny-1 2026-07-06T01:50:34.174Z monthly 0.5 https://novapharmanews.com/us/news/4-biotech-stocks-investors-should-watch-in-2026-market-analysis 2026-07-05T22:14:01.965Z monthly 0.5 https://novapharmanews.com/us/news/alabama-board-medical-examiners-warning-non-fda-approved-peptides 2026-07-05T16:53:52.141Z monthly 0.5 https://novapharmanews.com/us/news/vertex-fda-accepts-bla-povetacicept-iga-nephropathy-accelerated-approval 2026-07-06T16:28:53.832Z monthly 0.5 https://novapharmanews.com/us/news/aurobindo-pharma-oai-classification-drug-approvals 2026-07-06T16:16:18.190Z monthly 0.5 https://novapharmanews.com/us/news/lee-tuberville-introduce-protections-for-homeopathic-medicine-fda-approval-framework 2026-07-06T02:42:13.436Z monthly 0.5 https://novapharmanews.com/us/news/daraxonrasib-pancreatic-cancer-survival-2026 2026-07-06T17:55:32.659Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-ensitrelvir-xocova-first-oral-covid-19-post-exposure-prophylaxis 2026-07-05T18:11:39.370Z monthly 0.5 https://novapharmanews.com/us/news/generic-drugmakers-skinny-label-victory-hikma-amarin 2026-07-06T14:08:45.250Z monthly 0.5 https://novapharmanews.com/us/news/texas-ag-investigating-energy-drinks-pharma-implications 2026-07-04T17:19:54.970Z monthly 0.5 https://novapharmanews.com/eu/news/myasthenia-gravis-clinical-trial-pipeline-expands-25-companies-delveinsight 2026-07-06T01:32:16.827Z monthly 0.5 https://novapharmanews.com/eu/news/mfn-drug-pricing-reshapes-international-life-sciences-licensing-deals 2026-07-06T15:58:52.654Z monthly 0.5 https://novapharmanews.com/eu/news/india-oman-cepa-fast-tracks-drug-approvals-cuts-export-barriers 2026-07-04T00:29:41.314Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-companion-diagnostic-inavolisib-hr-her2-pik3ca-mutated-breast-cancer 2026-07-06T07:43:06.346Z monthly 0.5 https://novapharmanews.com/us/news/peptide-reclassification-rfk-jr-fda-announcement-pharmacist-take 2026-07-05T11:44:33.361Z monthly 0.5 https://novapharmanews.com/apac/news/vietnam-india-middle-power-diplomacy-pharma-market-analysis 2026-07-06T17:44:44.288Z monthly 0.5 https://novapharmanews.com/us/news/scientists-uncover-new-hiding-spot-hiv-bone-marrow 2026-07-05T06:54:03.817Z monthly 0.5 https://novapharmanews.com/us/news/trump-administration-strips-job-protections-nih-officials-pharma-impact 2026-07-06T04:43:47.053Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-drug-approvals-2025-record-first-global-approvals 2026-07-06T17:01:34.964Z monthly 0.5 https://novapharmanews.com/eu/news/ema-ama-african-regulators-ebola-clinical-trials-2026 2026-07-06T12:07:31.843Z monthly 0.5 https://novapharmanews.com/eu/news/cancer-therapy-ost-her2-2026-ema-call 2026-07-06T18:21:11.963Z monthly 0.5 https://novapharmanews.com/eu/news/esmo-asia-nadia-harbeck-oncology-advances 2026-07-06T17:46:49.771Z monthly 0.5 https://novapharmanews.com/apac/news/smarter-medical-devices-ecosystem-india-regulatory-updates 2026-07-06T17:38:40.991Z monthly 0.5 https://novapharmanews.com/eu/news/hayes-esmo-breast-cancer-award-2026 2026-07-06T17:09:18.914Z monthly 0.5 https://novapharmanews.com/apac/news/cell-gene-therapy-approvals-china-regulatory-updates 2026-07-06T17:00:34.280Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-recap 2026-07-06T16:55:07.713Z monthly 0.5 https://novapharmanews.com/us/news/fda-flashback-breast-cancer-april-2026 2026-07-06T16:40:27.251Z monthly 0.5 https://novapharmanews.com/eu/news/eu-commission-advances-critical-medicines-act 2026-07-06T16:01:31.908Z monthly 0.5 https://novapharmanews.com/eu/news/chmp-may-2026-output-shift-european-drug-development 2026-07-06T15:56:08.085Z monthly 0.5 https://novapharmanews.com/eu/news/who-europe-access-novel-medicines 2026-07-06T15:07:54.913Z monthly 0.5 https://novapharmanews.com/us/news/pharma-in-focus-regulatory-updates 2026-07-06T15:02:47.539Z monthly 0.5 https://novapharmanews.com/apac/news/decade-ai-medical-device-regulation-2015-2025 2026-07-06T11:08:09.324Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-daiichi-drug-approval-breast-cancer 2026-07-06T02:52:06.628Z monthly 0.5 https://novapharmanews.com/eu/news/chmp-negative-stance-acadia-rett-syndrome-drug 2026-07-05T22:14:12.693Z monthly 0.5 https://novapharmanews.com/eu/news/owkin-astrazeneca-ai-collaboration-drug-research 2026-07-05T11:28:09.048Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-first-oral-covid-19-pep-drug-xocova 2026-07-06T12:44:50.540Z monthly 0.5 https://novapharmanews.com/us/news/legend-biotech-in-vivo-car-t-lymphoma-data-surge 2026-07-06T14:17:20.286Z monthly 0.5 https://novapharmanews.com/us/news/halomd-lawsuit-update-highmark-health-no-surprises-act 2026-07-04T22:16:16.617Z monthly 0.5 https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-18-may-2026 2026-07-06T18:13:18.297Z monthly 0.5 https://novapharmanews.com/eu/news/us-europe-biosimilar-approvals-2026 2026-07-06T14:00:41.293Z monthly 0.5 https://novapharmanews.com/eu/news/key-cancer-drugs-esmo-2025 2026-07-06T15:38:42.746Z monthly 0.5 https://novapharmanews.com/us/news/stat-trump-s-medicaid-work-requirements-have-an-unwelcome-surprise-for-some-states-and-patients 2026-07-06T15:40:45.141Z monthly 0.5 https://novapharmanews.com/us/news/military-eating-disorders-prevalence-impact 2026-07-06T09:28:18.272Z monthly 0.5 https://novapharmanews.com/eu/news/european-navenibart-deal-biocryst-analysis 2026-07-06T13:30:57.833Z monthly 0.5 https://novapharmanews.com/apac/news/risen-pharma-phase-2-trial-rp902-alzheimers 2026-07-06T14:39:16.189Z monthly 0.5 https://novapharmanews.com/us/news/fda-blueprint-regulatory-risk-animal-testing-alternatives 2026-07-04T20:56:31.723Z monthly 0.5 https://novapharmanews.com/apac/news/regulatory-updates-optical-coherence-tomography-pharma 2026-07-06T11:08:18.049Z monthly 0.5 https://novapharmanews.com/us/news/china-drug-development-oncology-us 2026-07-06T08:21:26.067Z monthly 0.5 https://novapharmanews.com/eu/news/horizon-scanning-ema-regulatory-updates 2026-07-05T20:40:58.962Z monthly 0.5 https://novapharmanews.com/apac/news/datroway-approved-metastatic-tnbc 2026-07-06T10:11:02.472Z monthly 0.5 https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-positive-opinion-mavorixafor 2026-07-06T11:14:39.741Z monthly 0.5 https://novapharmanews.com/us/news/fda-declines-guidance-foreign-drug-imports 2026-07-06T06:33:31.938Z monthly 0.5 https://novapharmanews.com/eu/news/privosegtor-ema-prime-optic-neuritis 2026-07-06T17:47:10.060Z monthly 0.5 https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-cardiometabolic-data-european-a 2026-07-06T12:41:22.168Z monthly 0.5 https://novapharmanews.com/eu/news/teva-olan-ema-acceptance 2026-07-03T16:03:28.179Z monthly 0.5 https://novapharmanews.com/eu/news/florian-lordick-esmo-president-2026-elections-open 2026-07-05T19:58:34.028Z monthly 0.5 https://novapharmanews.com/us/news/ophthalmology-pipeline-milestones-q2-2026 2026-07-06T17:59:53.900Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-novo-wegovy-weight-loss-drug 2026-07-06T17:01:38.198Z monthly 0.5 https://novapharmanews.com/us/news/vir-biotechnology-stock-board-reshuffle-governance-votes 2026-07-06T16:54:12.647Z monthly 0.5 https://novapharmanews.com/apac/news/big-pharma-china-trials-scrutiny-oncology 2026-07-06T17:21:21.693Z monthly 0.5 https://novapharmanews.com/apac/news/premia-lind-lind-asia-ai-clinical-trials 2026-07-06T04:28:55.494Z monthly 0.5 https://novapharmanews.com/eu/news/definitive-trial-milestone-50-percent-recruitment 2026-07-04T12:11:47.031Z monthly 0.5 https://novapharmanews.com/apac/news/kissei-pharmaceutical-halts-tavneos-use-amid-deaths 2026-07-06T17:17:19.501Z monthly 0.5 https://novapharmanews.com/us/news/strengths-and-limitations-of-real-world-data-from-electronic-health-records-and-92ed37a9 2026-07-06T18:10:58.704Z monthly 0.5 https://novapharmanews.com/us/news/the-common-fund-data-ecosystem-cfde-449d7791 2026-07-05T18:14:26.411Z monthly 0.5 https://novapharmanews.com/us/news/the-gross-to-net-squeeze-how-physician-led-patient-education-reduces-gtn-erosion-17169d71 2026-07-06T13:33:40.794Z monthly 0.5 https://novapharmanews.com/us/news/a-secure-and-intelligent-drug-delivery-model-integrating-neural-networks-with-bl-853eecb6 2026-07-06T05:55:16.023Z monthly 0.5 https://novapharmanews.com/us/news/the-market-for-monoclonal-antibodies-trends-challenges-and-opportunities-7a342d06 2026-07-06T14:55:29.366Z monthly 0.5 https://novapharmanews.com/us/news/opinion-the-medical-billing-ai-arms-race-between-providers-and-insurance 2026-07-05T07:06:38.074Z monthly 0.5 https://novapharmanews.com/us/news/amish-healthcare-lessons-public-health 2026-07-05T18:06:38.674Z monthly 0.5 https://novapharmanews.com/us/news/nih-funding-cuts-ebola-preparedness-global-health 2026-07-02T18:17:39.535Z monthly 0.5 https://novapharmanews.com/us/news/ultra-processed-food-policy-demands-escalate-researchers-cite-systemic-issues 2026-06-20T19:48:00.877Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approves-new-pharmaceuticals-medical-devices-whats-new 2026-07-06T16:28:44.596Z monthly 0.5 https://novapharmanews.com/eu/news/eu-trade-policy-china-pharma-analysis 2026-07-06T16:06:11.330Z monthly 0.5 https://novapharmanews.com/eu/news/ema-january-drug-approvals-2025 2026-07-06T09:09:50.347Z monthly 0.5 https://novapharmanews.com/eu/news/chmp-drug-approvals-analysis 2026-07-06T18:08:57.784Z monthly 0.5 https://novapharmanews.com/us/news/munck-wilson-mandala-fort-worth-life-sciences-expansion 2026-07-05T23:33:09.764Z monthly 0.5 https://novapharmanews.com/us/news/fulcrum-therapeutics-stock-plunges-sickle-cell-drug-discontinuation 2026-07-06T04:33:39.418Z monthly 0.5 https://novapharmanews.com/us/news/senior-nih-scientist-research-fellow-charged-with-bringing-deactivated-mpox-virus-into-u-s 2026-07-03T00:39:00.902Z monthly 0.5 https://novapharmanews.com/us/news/cambridge-biotech-merger-acquisition-market-analysis 2026-07-06T07:04:13.263Z monthly 0.5 https://novapharmanews.com/us/news/outlook-therapeutics-lytenava-fda-resubmission-60-day-review 2026-07-06T13:31:20.802Z monthly 0.5 https://novapharmanews.com/us/news/hanmi-signs-licensing-deal-lilly-sonefpeglutide 2026-07-06T17:50:13.361Z monthly 0.5 https://novapharmanews.com/us/news/fda-final-guidance-pulmonary-tuberculosis-drug-development 2026-07-06T15:56:56.021Z monthly 0.5 https://novapharmanews.com/us/news/stat-pharmalittle-lilly-340b-ebola-vaccine-funding 2026-07-05T01:11:24.462Z monthly 0.5 https://novapharmanews.com/us/news/why-us-manufactured-pharmaceutical-packaging-equipment-matters 2026-07-06T06:11:29.914Z monthly 0.5 https://novapharmanews.com/us/news/virtual-end-doctors-office-waiting-room 2026-07-06T12:23:27.144Z monthly 0.5 https://novapharmanews.com/us/news/how-one-state-s-medical-meal-program-lowered-health-care-costs 2026-07-05T21:14:59.962Z monthly 0.5 https://novapharmanews.com/us/news/stat-corporate-medicine-telehealth-crackdown 2026-07-05T06:24:11.259Z monthly 0.5 https://novapharmanews.com/apac/news/global-rwe-guidance-regulatory-decision-making-updates 2026-07-04T04:53:56.407Z monthly 0.5 https://novapharmanews.com/apac/news/china-oncology-research-europe-alarm 2026-07-06T16:18:34.181Z monthly 0.5 https://novapharmanews.com/apac/news/asco-2026-asian-oncology-innovation-clinical-trials 2026-07-05T11:25:43.158Z monthly 0.5 https://novapharmanews.com/us/news/inventiva-leadership-lanifibranor-phase-3-data 2026-07-06T18:29:16.143Z monthly 0.5 https://novapharmanews.com/us/news/lilly-gilead-pharma-ma-boom-market-analysis 2026-07-06T17:55:53.928Z monthly 0.5 https://novapharmanews.com/eu/news/datroway-priority-review-metastatic-tnbc 2026-07-06T17:47:31.375Z monthly 0.5 https://novapharmanews.com/apac/news/dishman-carbogen-amcis-shanghai-nmpa-gmp-audit 2026-07-06T17:44:19.658Z monthly 0.5 https://novapharmanews.com/apac/news/newron-pharmaceuticals-june-investor-conferences 2026-07-06T17:38:20.671Z monthly 0.5 https://novapharmanews.com/eu/news/italy-fourth-europe-clinical-research-enrollment 2026-07-06T16:27:35.590Z monthly 0.5 https://novapharmanews.com/us/news/new-fda-approach-drug-prices-implications 2026-07-06T15:36:54.244Z monthly 0.5 https://novapharmanews.com/apac/news/hong-kong-new-drug-approval-process 2026-07-06T14:57:31.590Z monthly 0.5 https://novapharmanews.com/eu/news/fda-approves-aldosterone-synthase-inhibitor-hypertension 2026-07-06T14:30:13.168Z monthly 0.5 https://novapharmanews.com/eu/news/mayer-brown-serb-pharmaceuticals-idefirix-acquisition 2026-07-06T14:15:20.972Z monthly 0.5 https://novapharmanews.com/us/news/fda-expands-market-access-ends-products 2026-07-06T13:54:57.796Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-atezolizumab-ctdna-mrd-positive-mibc 2026-07-06T04:59:40.861Z monthly 0.5 https://novapharmanews.com/apac/news/beone-medicines-phase-3-herizon-gea-data-nejm 2026-07-06T04:03:54.602Z monthly 0.5 https://novapharmanews.com/us/news/longeveron-stockholder-letter-corporate-strategy-2026-goals 2026-07-05T17:18:26.148Z monthly 0.5 https://novapharmanews.com/us/news/fda-draft-guidance-biosimilar-pk-studies 2026-07-05T04:06:13.056Z monthly 0.5 https://novapharmanews.com/eu/news/ema-implements-new-eu-pharma-rules-regulatory-updates 2026-07-06T18:35:49.252Z monthly 0.5 https://novapharmanews.com/eu/news/regeneron-pharma-ema-eye-drug-review-wolfe-target-trim 2026-07-06T17:32:32.379Z monthly 0.5 https://novapharmanews.com/eu/news/teva-olanzapine-lai-ema-review-schizophrenia 2026-07-04T16:34:43.845Z monthly 0.5 https://novapharmanews.com/eu/news/asco-2026-european-pharma-astrazeneca-roche-market-analysis 2026-07-06T16:02:09.703Z monthly 0.5 https://novapharmanews.com/eu/news/esmo-2025-nmi-bladder-cancer-highlights 2026-07-06T12:43:11.577Z monthly 0.5 https://novapharmanews.com/eu/news/datroway-trodelvy-first-line-tnbc-battle 2026-07-06T18:34:11.575Z monthly 0.5 https://novapharmanews.com/us/news/citius-pharmaceuticals-stock-update-cancer-anti-infective 2026-07-06T18:30:17.252Z monthly 0.5 https://novapharmanews.com/eu/news/idorsia-c-diff-vaccine-clinical-progress 2026-07-06T17:07:07.229Z monthly 0.5 https://novapharmanews.com/us/news/fda-guidance-animal-thyroid-products-august-2026 2026-07-05T22:08:05.256Z monthly 0.5 https://novapharmanews.com/us/news/global-regulatory-roundup-june-1-2026 2026-07-06T17:30:55.106Z monthly 0.5 https://novapharmanews.com/us/news/biotech-m-and-a-trends-2026-outlook 2026-07-06T16:12:10.737Z monthly 0.5 https://novapharmanews.com/us/news/big-pharma-small-deals-biotech-boon 2026-07-06T14:45:31.081Z monthly 0.5 https://novapharmanews.com/us/news/rallybio-avenzo-reverse-merger-oncology-deal 2026-07-05T16:58:53.155Z monthly 0.5 https://novapharmanews.com/us/news/legend-biotech-asco-data-carvykti-lb2102 2026-07-06T17:50:58.280Z monthly 0.5 https://novapharmanews.com/us/news/cdc-ebola-containment-clinical-trials-priority 2026-07-06T11:13:08.874Z monthly 0.5 https://novapharmanews.com/us/news/asia-biopharma-innovation-epicenter-drug-approvals 2026-07-06T06:42:55.967Z monthly 0.5 https://novapharmanews.com/us/news/dea-reschedules-marijuana-schedule-iii-expediting-medical-access-research 2026-06-30T22:39:52.200Z monthly 0.5 https://novapharmanews.com/us/news/fda-expert-panel-review-peptide-access-compounded-drug-market 2026-07-06T12:03:12.731Z monthly 0.5 https://novapharmanews.com/us/news/elite-pharma-fda-anda-generic-anticoagulant-26b 2026-07-06T12:27:32.832Z monthly 0.5 https://novapharmanews.com/us/news/cms-finalizes-medicaid-work-requirement-rules 2026-07-06T18:00:55.389Z monthly 0.5 https://novapharmanews.com/us/news/medicus-pharma-biotech-showcase-2026 2026-07-06T16:48:48.921Z monthly 0.5 https://novapharmanews.com/us/news/rigel-pharmaceuticals-licenses-veppanu 2026-07-04T22:03:08.027Z monthly 0.5 https://novapharmanews.com/us/news/fda-ai-clinical-trials-rfi-guide 2026-07-05T20:10:51.692Z monthly 0.5 https://novapharmanews.com/apac/news/estado-actual-y-acciones-para-impulsar-la-investigacion-clinica-en-mexico-2025-5b7db092 2026-07-06T05:33:44.928Z monthly 0.5 https://novapharmanews.com/us/news/formycon-ag-geschaftsbericht-2025-5ff7fa30 2026-07-06T14:52:09.511Z monthly 0.5 https://novapharmanews.com/us/news/fda-approvals-oncology-jan-mar-2026 2026-07-06T17:40:53.308Z monthly 0.5 https://novapharmanews.com/us/news/2025-drug-approvals-biopharma-resilience 2026-07-06T17:24:36.103Z monthly 0.5 https://novapharmanews.com/us/news/top-biotech-gainers-codx-nrxp-nvax-clinical-trials-update 2026-07-06T14:01:35.421Z monthly 0.5 https://novapharmanews.com/us/news/fda-easing-restrictions-unproven-peptides 2026-07-06T12:58:24.328Z monthly 0.5 https://novapharmanews.com/us/news/bayer-acquisition-eye-drug-biotech 2026-07-06T12:40:42.441Z monthly 0.5 https://novapharmanews.com/us/news/fda-permanent-ban-compounded-glp-1s 2026-07-06T10:24:23.383Z monthly 0.5 https://novapharmanews.com/us/news/sunlight-glp-1-2026-fda-decision-compounded-semaglutide 2026-07-06T08:48:19.212Z monthly 0.5 https://novapharmanews.com/us/news/top-10-takeover-targets-2026 2026-07-06T04:09:32.537Z monthly 0.5 https://novapharmanews.com/us/news/us-fda-proposes-regulations-weight-loss-drug-compounding 2026-07-05T00:11:33.407Z monthly 0.5 https://novapharmanews.com/us/news/eli-lilly-acquires-centessa-pharmaceuticals-market-analysis 2026-07-04T00:48:08.562Z monthly 0.5 https://novapharmanews.com/us/news/fda-eases-restrictions-peptides-drug-approvals 2026-07-01T01:11:55.430Z monthly 0.5 https://novapharmanews.com/us/news/fda-peptides-bulk-drug-compounding 2026-06-23T17:12:36.870Z monthly 0.5 https://novapharmanews.com/us/news/healthcare-dealmaker-megamergers-2026 2026-07-06T17:00:28.946Z monthly 0.5 https://novapharmanews.com/eu/news/bio-pharma-outlook-2026-regulatory-updates 2026-07-06T16:46:44.685Z monthly 0.5 https://novapharmanews.com/eu/news/rethinking-qa-qc-future-bio-pharmaceutical-analysis-2026 2026-07-06T09:07:45.040Z monthly 0.5 https://novapharmanews.com/eu/news/fda-delays-astrazeneca-breast-cancer-drug-review 2026-07-06T08:45:00.219Z monthly 0.5 https://novapharmanews.com/us/news/fsma-final-rule-traceability-requirements 2026-07-06T01:55:51.299Z monthly 0.5 https://novapharmanews.com/apac/news/early-access-disparities-innovative-therapies 2026-07-06T00:48:22.980Z monthly 0.5 https://novapharmanews.com/eu/news/international-school-clinical-oncology-annual-congress-2026 2026-07-05T22:32:04.386Z monthly 0.5 https://novapharmanews.com/eu/news/2026-italy-drug-medical-device-litigation-report 2026-07-05T22:06:00.895Z monthly 0.5 https://novapharmanews.com/us/news/fda-guidance-next-gen-sequencing-gene-therapy-safety 2026-07-05T21:44:59.555Z monthly 0.5 https://novapharmanews.com/apac/news/pharmaceuticals-market-size-share-analysis-2034 2026-07-05T18:25:14.992Z monthly 0.5 https://novapharmanews.com/eu/news/ascentage-pharma-eha-2026-clinical-advances 2026-07-05T11:45:02.354Z monthly 0.5 https://novapharmanews.com/us/news/fda-decisions-q2-2026-drug-approvals 2026-07-06T17:59:54.004Z monthly 0.5 https://novapharmanews.com/us/news/altrx-glp-1-review-2026-fda-updates-semaglutide 2026-07-06T14:04:06.495Z monthly 0.5 https://novapharmanews.com/us/news/resilience-reinvention-biotech-maturity 2026-07-06T11:18:13.592Z monthly 0.5 https://novapharmanews.com/us/news/longeveron-q1-2026-financial-results-business-update 2026-07-05T23:03:44.662Z monthly 0.5 https://novapharmanews.com/us/news/china-approves-hernexeos-lung-cancer-treatment 2026-07-05T14:29:41.781Z monthly 0.5 https://novapharmanews.com/us/news/global-ma-trends-health-industries-2026-outlook 2026-07-01T09:18:09.263Z monthly 0.5 https://novapharmanews.com/us/news/wockhardt-us-fda-approval-zaynich 2026-06-30T13:45:25.695Z monthly 0.5 https://novapharmanews.com/us/news/pennsylvania-compounding-pharmacy-fda-warning-letter 2026-06-27T18:23:44.726Z monthly 0.5 https://novapharmanews.com/us/news/chinese-pharma-innovators-global-expansion 2026-06-19T08:18:23.396Z monthly 0.5 https://novapharmanews.com/apac/news/uk-clinical-trials-oncology-impact 2026-07-06T16:38:42.162Z monthly 0.5 https://novapharmanews.com/eu/news/innovent-pfizer-cancer-drug-deal 2026-07-06T13:17:05.583Z monthly 0.5 https://novapharmanews.com/us/news/lilly-38b-investment-infectious-disease-portfolio 2026-07-06T07:18:53.616Z monthly 0.5 https://novapharmanews.com/eu/news/lenz-therapeutics-vizz-ema-presbyopia 2026-07-06T07:02:36.518Z monthly 0.5 https://novapharmanews.com/apac/news/asia-pacific-eclinical-solutions-market-report-2025-2030 2026-07-05T16:21:17.039Z monthly 0.5 https://novapharmanews.com/eu/news/innovent-biologics-shares-surge-pfizer-deal 2026-07-05T13:23:35.780Z monthly 0.5 https://novapharmanews.com/apac/news/biomarkers-digital-technologies-oncology-asia-2026 2026-07-05T07:54:01.176Z monthly 0.5 https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-clinical-data-eas-congress 2026-07-05T00:30:45.911Z monthly 0.5 https://novapharmanews.com/apac/news/innovative-oncology-pharma-china 2026-07-04T10:39:29.500Z monthly 0.5 https://novapharmanews.com/us/news/fda-device-guidance-agenda-2026 2026-07-03T05:45:11.501Z monthly 0.5 https://novapharmanews.com/us/news/fda-new-guidance-ai-regulatory-restraint 2026-06-16T22:53:40.481Z monthly 0.5 https://novapharmanews.com/us/news/lunai-bioworks-brainstorm-therapeutics-ai-collaboration 2026-07-06T12:18:58.708Z monthly 0.5 https://novapharmanews.com/us/news/fda-commissioner-resignation-drug-approvals 2026-07-06T17:24:15.766Z monthly 0.5 https://novapharmanews.com/us/news/big-pharma-ma-spree-march-ipo-drought 2026-07-06T14:54:14.190Z monthly 0.5 https://novapharmanews.com/us/news/pharma-ma-boom-2026-market-analysis 2026-07-06T11:34:10.547Z monthly 0.5 https://novapharmanews.com/us/news/ai-breast-cancer-risk-prediction-tool-fda-approval 2026-07-06T09:26:40.592Z monthly 0.5 https://novapharmanews.com/us/news/big-pharma-biotech-assets-patent-cliff 2026-07-06T06:01:22.522Z monthly 0.5 https://novapharmanews.com/us/news/life-sciences-dealmaking-momentum-strategic-pressures 2026-07-05T21:52:28.523Z monthly 0.5 https://novapharmanews.com/us/news/regulatory-actions-may-2026 2026-07-05T19:00:09.596Z monthly 0.5 https://novapharmanews.com/us/news/ai-brain-organoids-parkinsons-rare-epilepsy-regulatory-updates 2026-07-05T18:10:13.365Z monthly 0.5 https://novapharmanews.com/us/news/bizengri-fda-national-priority-rare-bile-duct-cancer 2026-06-30T12:45:38.284Z monthly 0.5 https://novapharmanews.com/us/news/pharmtech-regulatory-roundup-may-2026-drug-approvals 2026-06-30T08:42:43.304Z monthly 0.5 https://novapharmanews.com/us/news/states-confront-medical-chatbots-oversight-fda-inaction 2026-06-29T16:40:54.631Z monthly 0.5 https://novapharmanews.com/eu/news/critical-medicines-act-council-parliament-deal 2026-07-06T16:01:55.281Z monthly 0.5 https://novapharmanews.com/eu/news/2026-cell-therapy-regulatory-landscape 2026-07-06T13:02:12.018Z monthly 0.5 https://novapharmanews.com/eu/news/prac-meeting-highlights-may-2026 2026-07-06T12:56:03.376Z monthly 0.5 https://novapharmanews.com/eu/news/merz-therapeutics-kvvit-inbrija-agreement 2026-07-06T00:32:14.211Z monthly 0.5 https://novapharmanews.com/apac/news/premia-lind-ai-clinical-trial-screening-asia-pacific 2026-07-06T00:13:03.695Z monthly 0.5 https://novapharmanews.com/eu/news/esmo-2025-preview-astra-daiichi-gilead 2026-07-05T23:48:45.935Z monthly 0.5 https://novapharmanews.com/eu/news/imfinzi-fda-approval-bladder-cancer 2026-07-05T18:31:53.167Z monthly 0.5 https://novapharmanews.com/apac/news/onconic-therapeutics-jakubo-phase-3-clinical-trials-china 2026-07-05T18:07:07.231Z monthly 0.5 https://novapharmanews.com/apac/news/clinical-trials-market-oncology-2034 2026-07-05T17:09:51.727Z monthly 0.5 https://novapharmanews.com/apac/news/innovent-biologics-pfizer-10-5b-oncology-partnership 2026-07-04T19:12:01.473Z monthly 0.5 https://novapharmanews.com/us/news/seven-biopharma-trends-2026-clinical-trials 2026-07-06T18:05:43.266Z monthly 0.5 https://novapharmanews.com/us/news/experimental-igg4-rd-drug-fda-submission 2026-07-06T17:41:33.970Z monthly 0.5 https://novapharmanews.com/apac/news/sun-pharma-organon-acquisition-market-analysis 2026-07-06T05:18:01.635Z monthly 0.5 https://novapharmanews.com/apac/news/middle-east-pharma-markets-api-china-2026 2026-07-05T21:29:41.292Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-durvalumab-bcg-high-risk-nmibc 2026-07-05T18:08:28.818Z monthly 0.5 https://novapharmanews.com/apac/news/global-drug-discovery-market-2035 2026-07-05T17:53:00.980Z monthly 0.5 https://novapharmanews.com/us/news/leap-therapeutics-stock-edges-higher 2026-06-25T19:03:08.203Z monthly 0.5 https://novapharmanews.com/eu/news/tarsier-pharma-ipo-nyse-listings-expand 2026-07-06T17:26:37.433Z monthly 0.5 https://novapharmanews.com/eu/news/hansa-licenses-idefirix-serb-133m 2026-07-06T17:09:29.053Z monthly 0.5 https://novapharmanews.com/eu/news/camizestrant-eu-approval-advanced-er-positive-breast-cancer 2026-07-06T16:41:46.360Z monthly 0.5 https://novapharmanews.com/apac/news/apac-clinical-trial-growth-oncology 2026-07-06T15:54:47.377Z monthly 0.5 https://novapharmanews.com/us/news/biopharma-dealmaking-2025-market-analysis 2026-07-06T14:53:24.236Z monthly 0.5 https://novapharmanews.com/apac/news/regulatory-strategy-reimagined-trends-accelerating-drug-development 2026-07-06T13:30:16.259Z monthly 0.5 https://novapharmanews.com/us/news/global-firms-china-deals-economic-uncertainty 2026-07-06T12:48:40.476Z monthly 0.5 https://novapharmanews.com/us/news/gsk-alfasigma-licensing-agreement-servier-acquisition 2026-07-06T08:13:56.683Z monthly 0.5 https://novapharmanews.com/eu/news/imfinzi-approved-bladder-cancer-combo 2026-07-06T05:17:00.901Z monthly 0.5 https://novapharmanews.com/eu/news/ema-management-board-march-2026-clinical-trials 2026-07-06T01:12:57.155Z monthly 0.5 https://novapharmanews.com/apac/news/exosome-based-therapeutics-market-2033-report 2026-07-05T18:14:05.101Z monthly 0.5 https://novapharmanews.com/us/news/us-fda-decision-date-camizestrant-extended 2026-07-05T17:53:12.786Z monthly 0.5 https://novapharmanews.com/us/news/fda-loosens-regulations-digital-health-tools 2026-07-05T04:01:19.108Z monthly 0.5 https://novapharmanews.com/eu/news/critical-medicines-act-europe-medicines-shortages 2026-07-05T03:54:48.402Z monthly 0.5 https://novapharmanews.com/apac/news/ai-tools-clinical-trials-life-sciences 2026-07-04T14:36:10.952Z monthly 0.5 https://novapharmanews.com/us/news/eli-lilly-acquires-vaccine-developers-38b 2026-07-06T16:27:49.413Z monthly 0.5 https://novapharmanews.com/eu/news/ai-accelerates-novo-nordisk-parkinsons-cell-therapy 2026-07-06T10:57:07.294Z monthly 0.5 https://novapharmanews.com/eu/news/european-critical-medicines-act-market-analysis 2026-07-06T02:54:47.287Z monthly 0.5 https://novapharmanews.com/apac/news/brenus-pharma-stc-1010-fda-acceptance 2026-07-06T18:27:54.750Z monthly 0.5 https://novapharmanews.com/apac/news/immunotherapy-pet-ct-imaging-demand-australia 2026-07-06T17:21:41.971Z monthly 0.5 https://novapharmanews.com/us/news/fda-restricts-compounding-weight-loss-drugs 2026-07-06T16:59:48.418Z monthly 0.5 https://novapharmanews.com/us/news/top-10-anticipated-drug-launches-2026 2026-07-06T08:14:02.984Z monthly 0.5 https://novapharmanews.com/us/news/lifesaving-upgrades-fda-oncology-approvals 2026-07-06T03:26:38.976Z monthly 0.5 https://novapharmanews.com/us/news/fda-guidelines-generic-bioequivalence-oncology 2026-07-05T20:55:18.875Z monthly 0.5 https://novapharmanews.com/apac/news/india-vietnam-relations-diplomatic-push 2026-07-05T08:51:24.901Z monthly 0.5 https://novapharmanews.com/eu/news/us-eu-pharmaceutical-regulations-concerns 2026-07-06T17:12:29.168Z monthly 0.5 https://novapharmanews.com/eu/news/may-2026-global-health-wash-funding-opportunities 2026-07-06T16:48:47.247Z monthly 0.5 https://novapharmanews.com/eu/news/eu-draft-deal-essential-medicine-shortages 2026-07-06T16:06:41.470Z monthly 0.5 https://novapharmanews.com/eu/news/ema-fda-good-ai-practice-drug-development 2026-07-06T07:06:02.257Z monthly 0.5 https://novapharmanews.com/eu/news/serd-therapy-anti-proliferative-activity-er-her2-breast-cancer 2026-07-06T05:50:35.174Z monthly 0.5 https://novapharmanews.com/eu/news/fda-real-time-clinical-trials-progress 2026-07-05T22:11:56.857Z monthly 0.5 https://novapharmanews.com/eu/news/europe-boost-clinical-trials 2026-07-05T04:15:48.251Z monthly 0.5 https://novapharmanews.com/apac/news/nuance-pharma-ind-clearance-actair-china 2026-07-04T18:28:26.517Z monthly 0.5 https://novapharmanews.com/us/news/sgs-acquires-keystone-bioanalytical-drug-development 2026-07-04T05:00:40.999Z monthly 0.5 https://novapharmanews.com/us/news/fda-clarifies-3-year-exclusivity-guidance 2026-07-02T03:05:38.742Z monthly 0.5 https://novapharmanews.com/us/news/industry-groups-fda-guidance-form-483 2026-07-01T23:06:30.680Z monthly 0.5 https://novapharmanews.com/us/news/chinas-licensing-boom-global-pipelines 2026-06-20T20:01:37.984Z monthly 0.5 https://novapharmanews.com/apac/news/lundbeck-korean-approval-vyepti-oncology-migraine 2026-07-06T18:28:05.037Z monthly 0.5 https://novapharmanews.com/apac/news/60-degrees-pharmaceuticals-tafenoquine-clinical-trial-babesiosis 2026-07-06T18:25:57.414Z monthly 0.5 https://novapharmanews.com/eu/news/critical-medicines-act-impact-pharmaceutical-manufacturing-europe 2026-07-06T14:03:25.627Z monthly 0.5 https://novapharmanews.com/us/news/astellas-xtandi-patent-cliff-strategic-moves 2026-07-06T07:48:48.030Z monthly 0.5 https://novapharmanews.com/eu/news/maat-pharma-q1-2026-business-update 2026-07-05T20:27:43.395Z monthly 0.5 https://novapharmanews.com/apac/news/bukwang-pharmaceutical-dreamcis-aws-clinical-trials 2026-07-05T19:53:53.810Z monthly 0.5 https://novapharmanews.com/us/news/best-biotech-stocks-may-2026-clinical-trials 2026-07-05T18:28:20.417Z monthly 0.5 https://novapharmanews.com/us/news/fda-vs-ema-camizestrant-controversy 2026-07-03T19:49:54.847Z monthly 0.5 https://novapharmanews.com/eu/news/esmo-breast-cancer-congress-2026-highlights 2026-07-05T22:47:03.740Z monthly 0.5 https://novapharmanews.com/us/news/fda-new-form-483-response-guidance 2026-07-05T07:50:26.518Z monthly 0.5 https://novapharmanews.com/apac/news/clinical-trials-day-2026-oncology-study-growth 2026-07-06T17:21:11.552Z monthly 0.5 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-competitive-headwinds 2026-07-06T17:19:50.791Z monthly 0.5 https://novapharmanews.com/us/news/fda-drug-approval-decisions-may-2026 2026-07-06T00:01:50.242Z monthly 0.5 https://novapharmanews.com/apac/news/health-news-round-up-immunotherapy-pcos-clopidogrel-trials 2026-07-05T17:42:54.725Z monthly 0.5 https://novapharmanews.com/us/news/liminatus-pharma-innocsai-merger-market-analysis 2026-07-03T13:50:42.482Z monthly 0.5 https://novapharmanews.com/eu/news/ireland-clinical-trials-eu-comparison 2026-06-28T01:36:07.868Z monthly 0.5 https://novapharmanews.com/eu/news/chmp-meeting-highlights-drug-approvals-april-2026 2026-07-06T18:33:41.062Z monthly 0.5 https://novapharmanews.com/apac/news/clinical-trials-day-2026-research-rising-oncology 2026-07-06T17:58:11.995Z monthly 0.5 https://novapharmanews.com/us/news/rfk-jr-drug-approval-speed-oncology 2026-07-06T16:59:38.258Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-17-drugs-continuous-manufacturing 2026-07-06T15:35:10.682Z monthly 0.5 https://novapharmanews.com/us/news/krystal-biotech-q1-earnings-beat-catalysts-2026-2027 2026-07-05T20:41:15.391Z monthly 0.5 https://novapharmanews.com/eu/news/eu-lawmakers-critical-medicines-act-deal 2026-07-05T11:22:47.958Z monthly 0.5 https://novapharmanews.com/eu/news/european-biotechs-cell-gene-therapy-manufacturing 2026-07-05T04:42:58.387Z monthly 0.5 https://novapharmanews.com/eu/news/efpia-warns-access-gap-us-pricing-reforms 2026-06-30T10:31:10.884Z monthly 0.5 https://novapharmanews.com/us/news/fda-fast-track-oncology-drugs-april-2026 2026-07-06T17:41:03.484Z monthly 0.5 https://novapharmanews.com/us/news/aptar-pharma-fda-research-contract-progress 2026-07-06T17:16:37.732Z monthly 0.5 https://novapharmanews.com/us/news/fda-guidance-animal-testing-alternatives-concerns 2026-07-06T17:15:43.487Z monthly 0.5 https://novapharmanews.com/us/news/best-cancer-stocks-2026-investment 2026-07-06T17:14:43.173Z monthly 0.5 https://novapharmanews.com/us/news/fda-in-flux-may-2026-drug-approvals-update 2026-07-06T17:14:33.882Z monthly 0.5 https://novapharmanews.com/apac/news/kelun-merck-lung-cancer-combo-china-trial 2026-07-06T00:07:54.383Z monthly 0.5 https://novapharmanews.com/eu/news/mhra-consultation-rare-disease-therapy 2026-06-30T01:39:25.613Z monthly 0.5 https://novapharmanews.com/apac/news/ildong-pharmaceutical-stock-earnings-pipeline-insights 2026-06-24T00:38:38.728Z monthly 0.5 https://novapharmanews.com/eu/news/first-glp-1-gene-therapy-clinical-trial-europe 2026-07-06T01:14:35.453Z monthly 0.5 https://novapharmanews.com/us/news/new-fda-guidance-ends-nicotine-pouches 2026-07-04T22:06:13.814Z monthly 0.5 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-biotech 2026-07-04T22:05:52.466Z monthly 0.5 https://novapharmanews.com/us/news/takeda-novartis-layoffs-pharma-impact 2026-07-06T06:54:08.136Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-pharma-stock-institutional-buying-insights 2026-07-06T05:05:41.139Z monthly 0.5 https://novapharmanews.com/us/news/fda-alert-pulmonology-drug-approvals 2026-07-05T16:12:33.943Z monthly 0.5 https://novapharmanews.com/us/news/fda-lifting-restrictions-compounded-peptides 2026-07-05T13:56:03.336Z monthly 0.5 https://novapharmanews.com/us/news/2026-pharma-ma-breakout-year 2026-07-05T12:57:08.024Z monthly 0.5 https://novapharmanews.com/apac/news/zte-partners-china-national-clinical-research-center 2026-07-06T17:21:01.412Z monthly 0.5 https://novapharmanews.com/eu/news/february-batch-novel-medicines-ema-chmp-approval 2026-07-06T10:39:40.937Z monthly 0.5 https://novapharmanews.com/apac/news/novartis-pluvicto-stronger-psa-responses-prostate-cancer 2026-07-06T07:41:39.402Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-2026-recap 2026-07-06T16:20:57.071Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-recap 2026-07-06T15:02:57.916Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-annual-recap 2026-07-06T11:14:21.121Z monthly 0.5 https://novapharmanews.com/us/news/sellas-nears-key-aml-data-dual-trials 2026-07-05T03:25:57.210Z monthly 0.5 https://novapharmanews.com/eu/news/global-pharmacovigilance-reporting-comparative-analysis 2026-07-04T22:00:57.513Z monthly 0.5 https://novapharmanews.com/us/news/fda-bayesian-methodology-drug-development 2026-07-04T20:04:52.545Z monthly 0.5 https://novapharmanews.com/eu/news/cma-deal-eu-medicine-supply-chains-analysis 2026-07-04T22:06:35.299Z monthly 0.5 https://novapharmanews.com/apac/news/asia-pacific-regulatory-updates-tga-guidance 2026-07-04T22:06:14.117Z monthly 0.5 https://novapharmanews.com/us/news/top-10-biopharma-ma-deals-2025 2026-07-04T23:16:28.556Z monthly 0.5 https://novapharmanews.com/eu/news/europes-drug-innovation-edge-risk-dutch-industry-group 2026-07-04T22:07:36.340Z monthly 0.5 https://novapharmanews.com/eu/news/future-european-medicine-clinical-research 2026-07-04T22:06:12.484Z monthly 0.5 https://novapharmanews.com/eu/news/breast-cancer-experts-esmo-2026-abstracts-preview 2026-07-06T17:29:32.263Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-atezolizumab-muscle-invasive-bladder-cancer 2026-07-06T13:49:35.776Z monthly 0.5 https://novapharmanews.com/us/news/ma-in-pharmaceuticals-market-analysis 2026-07-04T23:56:56.388Z monthly 0.5 https://novapharmanews.com/eu/news/q1-2026-life-sciences-law-update-clinical-trials 2026-07-04T22:05:48.610Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-antibody-treatment-maker-autoimmune-disease 2026-07-06T13:56:27.854Z monthly 0.5 https://novapharmanews.com/apac/news/asia-bacitracin-ointment-market-analysis-regulatory-updates 2026-07-06T12:11:17.687Z monthly 0.5 https://novapharmanews.com/eu/news/regulatory-round-up-may-11-2026 2026-07-05T22:46:09.682Z monthly 0.5 https://novapharmanews.com/apac/news/india-cdsco-prior-intimation-system-clinical-trials 2026-07-05T14:42:39.589Z monthly 0.5 https://novapharmanews.com/eu/news/ema-critical-medicines-act-market-analysis 2026-07-04T22:05:51.315Z monthly 0.5 https://novapharmanews.com/us/news/big-pharma-ma-mega-year-patent-expiries 2026-07-04T22:05:35.208Z monthly 0.5 https://novapharmanews.com/us/news/pharma-ma-roundup-april-2026 2026-07-06T14:09:53.387Z monthly 0.5 https://novapharmanews.com/us/news/10-clinical-trials-to-watch-2026 2026-07-06T06:11:37.204Z monthly 0.5 https://novapharmanews.com/us/news/regulatory-round-up-fda-cancer-drug-approvals 2026-07-06T00:23:12.416Z monthly 0.5 https://novapharmanews.com/apac/news/the-week-in-pharma-action-reaction-insight-may-15-2026 2026-07-06T00:19:54.104Z monthly 0.5 https://novapharmanews.com/eu/news/europes-biotech-dilemma-discovery-scale-clinical-trials 2026-07-04T22:07:38.426Z monthly 0.5 https://novapharmanews.com/us/news/fda-leadership-changes-crisis-drug-approvals 2026-07-04T22:06:32.935Z monthly 0.5 https://novapharmanews.com/us/news/makary-resigns-fda-commissioner-drug-approvals 2026-07-04T22:07:51.854Z monthly 0.5 https://novapharmanews.com/us/news/fda-oncology-drug-approvals-2026 2026-07-06T17:55:57.359Z monthly 0.5 https://novapharmanews.com/us/news/four-fda-actions-reshaping-drug-development-2026 2026-07-06T17:14:55.118Z monthly 0.5 https://novapharmanews.com/eu/news/latest-new-meds-ema-chmp-approval 2026-07-06T16:02:38.832Z monthly 0.5 https://novapharmanews.com/us/news/fda-policy-tracker-2026-psychedelics-regulatory-updates 2026-07-06T15:50:08.463Z monthly 0.5 https://novapharmanews.com/eu/news/esmo-updates-ovarian-cancer-guidelines 2026-07-06T15:20:52.624Z monthly 0.5 https://novapharmanews.com/us/news/fda-blocks-melanoma-drug-confusion-makary 2026-07-06T00:10:20.859Z monthly 0.5 https://novapharmanews.com/us/news/fda-dual-approval-tdxd-her2-early-breast-cancer 2026-07-05T22:12:37.916Z monthly 0.5 https://novapharmanews.com/us/news/amgen-inc-stock-lung-cancer-setback-steady-cash-flow 2026-07-05T14:21:16.588Z monthly 0.5 https://novapharmanews.com/eu/news/countries-compete-reform-trials-global-sponsors 2026-07-04T22:06:32.293Z monthly 0.5 https://novapharmanews.com/us/news/6-biotechs-next-ma-target 2026-07-02T12:03:36.425Z monthly 0.5 https://novapharmanews.com/eu/news/20-posts-not-to-miss-esmo-breast-cancer-congress-2026 2026-07-06T08:32:55.779Z monthly 0.5 https://novapharmanews.com/eu/news/crinetics-palsonify-sales-enrollment-updates 2026-07-05T21:55:19.685Z monthly 0.5 https://novapharmanews.com/apac/news/fierce-pharma-asia-bms-hengrui-takeda-daiichi 2026-07-05T19:32:31.135Z monthly 0.5 https://novapharmanews.com/us/news/novel-drug-approvals-2026-fda 2026-07-06T14:38:54.455Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-event-daily-roundup 2026-07-06T16:15:30.180Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-event-biotech-innovation-us 2026-07-06T14:05:24.137Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-debuts-for-pharma-insights 2026-07-06T17:26:35.619Z monthly 0.5 https://novapharmanews.com/us/news/dia-2024-regulatory-preview 2026-07-06T09:57:39.927Z monthly 0.5 https://novapharmanews.com/us/news/dia-2024-regulatory-affairs-preview 2026-07-06T16:21:07.261Z monthly 0.5 https://novapharmanews.com/us/news/dia-2024-event-preview 2026-07-04T04:09:00.055Z monthly 0.5 https://novapharmanews.com/us/news/dia-2024-regulatory-conference-preview 2026-07-05T03:15:09.835Z monthly 0.5 https://novapharmanews.com/us/news/bio-it-world-conference-oncology-day-1 2026-07-06T09:38:48.847Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2024-highlights-us 2026-07-06T16:21:17.427Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-highlights-trends 2026-07-06T11:59:58.222Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-biotech-research-us 2026-07-03T00:37:42.571Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-highlights-us-implications 2026-07-05T19:56:22.041Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-daily-highlights 2026-07-06T14:39:47.745Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-daily-roundup 2026-07-06T14:50:55.992Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-highlights 2026-07-05T09:10:21.159Z monthly 0.5 https://novapharmanews.com/us/news/us-japan-healthcare-conf-2026-highlights 2026-07-06T18:00:52.469Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-highlights-trends 2026-07-06T15:32:45.797Z monthly 0.5 https://novapharmanews.com/apac/news/pda-manufacturing-apac-highlights 2026-07-06T15:46:02.644Z monthly 0.5 https://novapharmanews.com/us/news/bionj-biopartnering-conference-highlights 2026-07-06T13:22:14.462Z monthly 0.5 https://novapharmanews.com/us/news/asgct-manufacturing-innovations-day1 2026-07-06T13:14:45.999Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements-day-1-roundup 2026-07-05T14:02:26.734Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-record-q1-revenue-wegovy-ozempic 2026-07-06T16:05:55.508Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-cost-effectiveness 2026-07-06T14:47:58.098Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day-1-roundup 2026-07-06T17:38:30.843Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-eu-manufacturing-day-1 2026-07-06T14:14:33.185Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2024-day-1-gene-therapy-advancements 2026-07-05T20:56:47.762Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-day-1-roundup 2026-07-06T06:26:15.623Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-day1-us-biotech-trends 2026-07-06T18:16:11.260Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-us-biotech-investors 2026-07-06T12:51:36.741Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-innovations 2026-07-06T15:00:01.942Z monthly 0.5 https://novapharmanews.com/us/news/bionj-biopartnering-conference-day-1-highlights 2026-07-06T16:08:25.254Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-day-1-biotech-innovation 2026-07-06T16:40:57.754Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-day-1-roundup 2026-07-06T11:39:39.480Z monthly 0.5 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day1-policy-tech 2026-07-04T20:59:00.256Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-day-1-roundup 2026-07-06T11:07:07.394Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-innovations-trends 2026-07-06T03:12:06.683Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-daily-roundup 2026-07-06T08:12:17.188Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day1 2026-07-06T11:46:45.348Z monthly 0.5 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day1-highlights 2026-07-05T15:04:56.660Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-manufacturing-day-1-roundup 2026-07-06T01:38:50.041Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-manufacturing-day-1-roundup 2026-07-06T09:58:06.031Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-highlights-key-trends 2026-07-06T02:42:19.623Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-highlights 2026-07-06T02:15:30.562Z monthly 0.5 https://novapharmanews.com/apac/news/apac-clinical-event-preview 2026-07-06T14:33:40.280Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-eu-manufacturing-day-1-roundup 2026-07-06T10:51:35.351Z monthly 0.5 https://novapharmanews.com/us/news/asgct-manufacturing-innovations 2026-07-04T21:00:14.871Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-daily-roundup 2026-07-06T15:59:01.338Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements 2026-07-06T16:40:17.071Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-highlights-us 2026-07-06T17:00:18.755Z monthly 0.5 https://novapharmanews.com/us/news/fdli-2026-annual-highlights 2026-07-06T14:06:59.945Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-highlights-innovations 2026-07-06T12:43:55.075Z monthly 0.5 https://novapharmanews.com/us/news/APHL-2026-annual-day-1-roundup 2026-07-05T22:17:00.759Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-highlights 2026-07-06T14:49:53.669Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-key-takeaways 2026-07-06T16:27:45.725Z monthly 0.5 https://novapharmanews.com/us/news/ipec-annual-meeting-highlights-us 2026-07-05T21:19:29.657Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates 2026-07-06T01:00:15.237Z monthly 0.5 https://novapharmanews.com/us/news/fdli-annual-2026-daily-roundup 2026-07-06T14:06:59.945Z monthly 0.5 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-insights-policy-updates 2026-07-06T17:28:46.760Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-day-1-roundup 2026-07-06T14:21:58.982Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-key-innovations-partnerships 2026-07-06T18:34:04.894Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-day-1-highlights 2026-07-06T16:46:34.501Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates-day-1 2026-07-05T09:20:05.626Z monthly 0.5 https://novapharmanews.com/apac/news/cryoport-q1-2026-financial-results-clinical-trials-cell-gene-therapy 2026-07-06T12:05:04.530Z monthly 0.5 https://novapharmanews.com/apac/news/ascidian-acdn-01-stellar-trial-stargardt-disease-dose-escalation-complete 2026-07-06T11:16:32.324Z monthly 0.5 https://novapharmanews.com/apac/news/quiver-bioscience-nih-heal-grant-qv-2421-chronic-pain-trials 2026-07-05T22:47:09.139Z monthly 0.5 https://novapharmanews.com/apac/news/lunai-bioworks-20-million-cns-drug-delivery-alzheimer-treatment 2026-07-05T12:29:54.903Z monthly 0.5 https://novapharmanews.com/apac/news/stryker-australia-tga-approval-temporomandibular-joint-prosthesis 2026-07-06T18:14:32.335Z monthly 0.5 https://novapharmanews.com/apac/news/tga-section-41hd-medical-device-emergency-import-approvals-australia 2026-07-06T17:19:41.081Z monthly 0.5 https://novapharmanews.com/eu/news/biotheryx-btx-9341-phase-1a-results-esmo-breast-cancer-congress-2026 2026-07-06T14:35:00.659Z monthly 0.5 https://novapharmanews.com/us/news/palvella-qtorin-rapamycin-phase-2-trial-angiokeratomas 2026-07-06T15:49:31.816Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-biosciences-nbip-2118-phase-1-obesity-trial 2026-07-06T12:25:32.012Z monthly 0.5 https://novapharmanews.com/us/news/caplyta-lumateperone-tops-adjunctive-depression-treatments-meta-analysis 2026-07-06T09:42:49.108Z monthly 0.5 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0802-phase-2a-trial-steroid-refractory-gvhd 2026-07-06T01:26:35.503Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-veppanu-breast-cancer-diagnostic 2026-07-06T14:51:14.968Z monthly 0.5 https://novapharmanews.com/us/news/opus-genetics-opgx-lca5-fda-rare-disease-evidence-program 2026-07-06T17:44:31.296Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-day-1-roundup 2026-07-06T17:48:52.496Z monthly 0.5 https://novapharmanews.com/eu/news/heart-failure-2026-vutrisiran-data-european-pharma-news 2026-07-06T13:26:23.039Z monthly 0.5 https://novapharmanews.com/apac/news/telix-tlx250-px-zircaix-kidney-cancer-diagnosis-phase-3-zircon 2026-07-06T17:55:21.073Z monthly 0.5 https://novapharmanews.com/apac/news/mifepristone-access-supreme-court-hold-planned-parenthood-5th-circuit 2026-07-06T16:02:20.234Z monthly 0.5 https://novapharmanews.com/eu/news/cvrx-benefit-hf-trial-barostim-heart-failure-first-patient 2026-07-06T18:16:17.156Z monthly 0.5 https://novapharmanews.com/eu/news/agenus-q1-2026-financial-report-botensilimab-balstilimab-update 2026-07-05T22:17:21.688Z monthly 0.5 https://novapharmanews.com/eu/news/oncolytics-biotech-pelareorep-colorectal-cancer-durable-responses 2026-07-06T06:09:45.705Z monthly 0.5 https://novapharmanews.com/eu/news/crispr-therapeutics-q1-2026-casgevy-global-approval 2026-07-06T18:08:23.384Z monthly 0.5 https://novapharmanews.com/us/news/takeda-tak-881-positive-phase-2-3-results-primary-immunodeficiency-disease 2026-07-05T05:28:05.245Z monthly 0.5 https://novapharmanews.com/us/news/accord-healthcare-relaunches-tadalafil-tablets-generic-ed-treatment 2026-07-06T14:52:57.575Z monthly 0.5 https://novapharmanews.com/us/news/inspiremd-fda-approval-switchguard-neuro-protection-cguardians-iii-trial 2026-07-06T15:25:37.584Z monthly 0.5 https://novapharmanews.com/apac/news/spontan-phase-ii-data-10-minute-onset-fda-requirements-erectile-dysfunction 2026-07-06T11:18:49.626Z monthly 0.5 https://novapharmanews.com/apac/news/ironwood-pharmaceuticals-short-bowel-syndrome-tpn-survey-ddw-2026 2026-07-06T12:42:55.636Z monthly 0.5 https://novapharmanews.com/apac/news/novo-nordisk-wegovy-china-launch-eli-lilly-obesity-market 2026-07-06T14:08:03.128Z monthly 0.5 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-tga-approval-redemplo-plozasiran-australia-fcs 2026-07-05T19:37:51.016Z monthly 0.5 https://novapharmanews.com/apac/news/biomarin-palynziq-fda-approval-adolescent-pku-patients 2026-07-06T17:26:28.745Z monthly 0.5 https://novapharmanews.com/apac/news/rois-us-expansion-global-cdmo-fda-approval-injectable-manufacturing 2026-07-06T17:41:54.118Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-travere-filspari-fsgs-treatment-adults-children 2026-07-04T12:04:35.074Z monthly 0.5 https://novapharmanews.com/eu/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-launch 2026-07-06T16:39:17.856Z monthly 0.5 https://novapharmanews.com/eu/news/takeda-tak-881-phase-3-trial-primary-immunodeficiency-disease-results 2026-07-05T06:56:44.091Z monthly 0.5 https://novapharmanews.com/eu/news/pulse-biosciences-atrial-fibrillation-treatment-100-percent-success-rate-2026 2026-07-06T15:30:35.550Z monthly 0.5 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-subcut-hf-ii-trial-results-heart-failure-2026 2026-07-06T15:18:32.412Z monthly 0.5 https://novapharmanews.com/eu/news/krystal-biotech-q1-2026-results-vyjuvek-expansion-registrational-studies 2026-07-06T08:22:33.616Z monthly 0.5 https://novapharmanews.com/eu/news/acurx-dna-pol-iiic-inhibitors-microbiome-preservation-mrsa-escmid-2026 2026-07-06T12:09:23.291Z monthly 0.5 https://novapharmanews.com/eu/news/biocryst-navenibart-european-licensing-deal-neopharmed-gentili 2026-07-06T07:59:38.133Z monthly 0.5 https://novapharmanews.com/eu/news/biosimulation-market-11-billion-2031-drug-development 2026-07-06T04:53:05.455Z monthly 0.5 https://novapharmanews.com/eu/news/grin-therapeutics-phase-3-beeline-study-radiprodil-europe-grin-ndd 2026-07-05T11:57:35.650Z monthly 0.5 https://novapharmanews.com/eu/news/vertex-casgevy-gene-therapy-global-expansion-q1-2026-results 2026-07-06T17:16:48.388Z monthly 0.5 https://novapharmanews.com/eu/news/nuvation-bio-ibtrozi-q1-2026-revenue-ros1-nsclc 2026-07-06T14:58:43.760Z monthly 0.5 https://novapharmanews.com/us/news/crispr-therapeutics-casgevy-global-approvals-60000-patients 2026-07-05T17:46:59.897Z monthly 0.5 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-pathway-als-treatment 2026-07-06T13:32:07.104Z monthly 0.5 https://novapharmanews.com/us/news/atossa-therapeutics-fda-rare-pediatric-disease-designation-z-endoxifen-mccune-albright-syndrome 2026-07-06T12:57:07.442Z monthly 0.5 https://novapharmanews.com/us/news/mbiota-elemental-ibs-treatment-ddw-2026-clinical-trial 2026-07-06T02:56:59.583Z monthly 0.5 https://novapharmanews.com/us/news/novartis-fabhalta-health-canada-approval-c3g-treatment 2026-07-06T10:25:03.476Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-cellectar-waldenstrom-macroglobulinemia 2026-07-05T16:27:03.122Z monthly 0.5 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-pancreatic-cancer-trials-ddw-2026 2026-07-06T02:58:07.340Z monthly 0.5 https://novapharmanews.com/us/news/cytokinetics-aficamten-phase-3-trial-results-non-obstructive-hypertrophic-cardiomyopathy-may-2026 2026-07-05T03:22:21.827Z monthly 0.5 https://novapharmanews.com/us/news/inflarx-izicopan-reactive-metabolite-liver-safety-study 2026-07-04T11:03:41.727Z monthly 0.5 https://novapharmanews.com/us/news/macrogenics-expands-zynyz-royalty-agreement-sagard-healthcare 2026-07-06T06:25:44.201Z monthly 0.5 https://novapharmanews.com/us/news/akebia-vadadustat-mortality-reduction-kidney-disease-jasn-study 2026-07-06T05:28:33.679Z monthly 0.5 https://novapharmanews.com/us/news/inflarx-izicopan-favorable-liver-metabolism-safety-profile-2026 2026-07-06T05:22:36.793Z monthly 0.5 https://novapharmanews.com/us/news/celcuity-gedatolisib-phase-3-viktoria-1-trial-pik3ca-mutant-cancer 2026-07-06T13:16:44.576Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-langlara-interchangeable-biosimilar-lantus-insulin-lannett 2026-07-05T16:38:28.618Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis 2026-07-06T12:01:01.623Z monthly 0.5 https://novapharmanews.com/us/news/arvinas-veppanu-vepdegestrant-fda-approval-first-protac-drug-esr1-breast-cancer 2026-07-06T17:59:07.868Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-daily-roundup 2026-07-05T02:09:41.237Z monthly 0.5 https://novapharmanews.com/us/news/APHL-2026-annual-meeting-day-1-highlights 2026-07-05T17:01:44.992Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-day-1-roundup 2026-07-05T16:45:38.084Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-daily-roundup 2026-07-06T03:54:06.573Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-new-mdd-treatment 2026-07-06T02:52:44.757Z monthly 0.5 https://novapharmanews.com/apac/news/sun-pharma-organon-partnership-india 2026-07-06T16:37:54.868Z monthly 0.5 https://novapharmanews.com/eu/news/purdue-pharma-shutdown-oxycontin-settlement 2026-07-06T13:43:19.264Z monthly 0.5 https://novapharmanews.com/eu/news/eular-2026-immutep-imp761-phase-1-preview 2026-07-06T14:15:58.259Z monthly 0.5 https://novapharmanews.com/us/news/thma-pharmacy-growth-priorities-2026 2026-07-05T08:21:06.449Z monthly 0.5 https://novapharmanews.com/us/news/cphi-americas-2026-pharma-manufacturing-trends 2026-07-05T19:55:46.422Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-day-1-highlights 2026-07-05T12:33:17.542Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-roundup 2026-07-06T02:47:37.940Z monthly 0.5 https://novapharmanews.com/apac/news/ucb-acquires-candid-therapeutics-2-2-billion-t-cell-engager-autoimmune 2026-07-06T15:47:28.007Z monthly 0.5 https://novapharmanews.com/eu/news/novelty-nobility-agc-biologics-bispecific-antibody-manufacturing-partnership 2026-07-04T23:58:38.749Z monthly 0.5 https://novapharmanews.com/eu/news/smartee-denti-technology-mandibular-repositioning-eas-congress-2026 2026-07-06T15:08:54.018Z monthly 0.5 https://novapharmanews.com/us/news/xtalpi-pep08-prmt5-inhibitor-phase-1-cancer-trial-enrollment 2026-07-06T09:45:18.020Z monthly 0.5 https://novapharmanews.com/us/news/mirum-pharmaceuticals-vistas-volixibat-primary-sclerosing-cholangitis-results-may-2026 2026-07-05T16:38:30.832Z monthly 0.5 https://novapharmanews.com/us/news/everads-therapy-suprachoroidal-injector-clinical-data-ophthalmology-science 2026-07-05T00:01:23.795Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-candid-therapeutics-autoimmune-deal 2026-07-05T12:41:32.614Z monthly 0.5 https://novapharmanews.com/us/news/spinogenix-tazbentetol-neuroprotective-glaucoma-diabetic-retinopathy-arvo-2026 2026-07-06T16:02:52.917Z monthly 0.5 https://novapharmanews.com/us/news/niktimvo-axatilimab-approved-australia-chronic-gvhd-treatment 2026-07-05T21:02:14.373Z monthly 0.5 https://novapharmanews.com/us/news/ipec-annual-meeting-2026-no-pharma-news 2026-07-05T19:30:50.624Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-ai-oncology-microbiome 2026-07-06T18:19:47.054Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-2026-daily-roundup 2026-07-05T04:56:44.285Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-meeting-opens-public-health-lab-focus 2026-07-06T00:26:45.072Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-mdd-new-antidepressant 2026-07-06T17:42:37.660Z monthly 0.5 https://novapharmanews.com/eu/news/purdue-pharma-dissolution-approved-opioid-crisis 2026-07-06T18:20:27.588Z monthly 0.5 https://novapharmanews.com/eu/news/auvelity-fda-approval-axsome-therapeutics 2026-07-06T12:07:20.553Z monthly 0.5 https://novapharmanews.com/us/news/axsome-fda-approval-alzheimers-agitation 2026-07-05T16:15:49.728Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-first-non-antipsychotic-dementia-agitation 2026-07-04T21:39:44.154Z monthly 0.5 https://novapharmanews.com/apac/news/a2-milk-company-recalls-platinum-infant-formula-health-risk 2026-07-05T03:53:29.226Z monthly 0.5 https://novapharmanews.com/us/news/edwards-lifesciences-resilia-tissue-10-year-durability-aortic-valve-trial 2026-07-05T02:33:13.711Z monthly 0.5 https://novapharmanews.com/us/news/biomarin-voxzogo-achondroplasia-long-term-data-pes-2026 2026-07-06T18:12:57.537Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis-polycythemia-vera 2026-07-06T15:59:06.494Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-axsome-therapeutics-mdd 2026-07-06T17:42:37.859Z monthly 0.5 https://novapharmanews.com/us/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-07-06T02:25:30.381Z monthly 0.5 https://novapharmanews.com/apac/news/vector-science-therapeutics-microneedle-catheter-patent-intratumoral-drug-delivery 2026-07-06T13:47:19.387Z monthly 0.5 https://novapharmanews.com/apac/news/apotex-generic-ozempic-semaglutide-health-canada-approval-2026 2026-07-06T10:01:16.283Z monthly 0.5 https://novapharmanews.com/apac/news/keenova-terlivaz-terlipressin-clinical-data-digestive-disease-week-2026 2026-07-04T12:52:20.366Z monthly 0.5 https://novapharmanews.com/apac/news/kodiak-sciences-ksi-101-clinical-data-macular-edema-conferences 2026-07-05T19:56:02.329Z monthly 0.5 https://novapharmanews.com/eu/news/synbiotech-microbiome-womens-healthy-aging-vitafoods-2026 2026-07-05T18:12:46.720Z monthly 0.5 https://novapharmanews.com/eu/news/curaleaf-torsten-greif-board-appointment-european-cannabis 2026-07-06T13:01:47.561Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-manufacturing-software-market-787-billion-2030 2026-07-05T20:25:37.346Z monthly 0.5 https://novapharmanews.com/eu/news/goodrx-ozempic-pill-type-2-diabetes-149-monthly 2026-07-05T16:17:24.514Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-crenessity-two-year-pediatric-cah-study-results 2026-07-05T18:40:03.749Z monthly 0.5 https://novapharmanews.com/us/news/cairn-surgical-breast-cancer-locator-system-pivotal-trial-results 2026-07-06T05:40:11.974Z monthly 0.5 https://novapharmanews.com/us/news/restore-vision-rv-001-gene-therapy-retinitis-pigmentosa-clinical-results 2026-07-04T05:06:57.876Z monthly 0.5 https://novapharmanews.com/us/news/archimed-acquires-esperion-therapeutics-cardiometabolic-deal-2026 2026-07-06T17:25:21.426Z monthly 0.5 https://novapharmanews.com/us/news/oculis-dme-research-arvo-2026-presentation 2026-07-06T18:00:24.895Z monthly 0.5 https://novapharmanews.com/us/news/rhythm-pharmaceuticals-imcivree-european-commission-approval-hypothalamic-obesity 2026-07-06T01:11:38.446Z monthly 0.5 https://novapharmanews.com/us/news/atara-biotherapeutics-ebvallo-fda-complete-response-letter-securities-lawsuit 2026-07-06T11:12:56.456Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-oral-ozempic-fda-approved-pill-glp1-type-2-diabetes-cardiovascular 2026-07-06T12:46:36.928Z monthly 0.5 https://novapharmanews.com/us/news/zeta-surgical-fda-clearance-brain-surgery-navigation-system 2026-07-06T03:48:05.995Z monthly 0.5 https://novapharmanews.com/us/news/viatris-low-dose-estrogen-contraceptive-patch-acog-2026 2026-07-06T16:17:46.408Z monthly 0.5 https://novapharmanews.com/us/news/axsome-auvelity-fda-approval-alzheimers-agitation-treatment 2026-07-06T13:37:12.185Z monthly 0.5 https://novapharmanews.com/us/news/arvinas-fda-approval-veppanu-vepdegestrant-protac-esr1-breast-cancer 2026-07-06T18:00:28.256Z monthly 0.5 https://novapharmanews.com/eu/news/plozasiran-tga-approval-australia-fcs 2026-07-06T17:47:20.208Z monthly 0.5 https://novapharmanews.com/us/news/moderna-fda-talks-phase-4-covid-vaccine-data 2026-07-06T05:19:23.019Z monthly 0.5 https://novapharmanews.com/apac/news/namsa-lexitas-partnership-ophthalmic-medical-device-development 2026-07-06T16:57:07.950Z monthly 0.5 https://novapharmanews.com/apac/news/verified-clinical-trials-chubb-partnership-patient-safety-data-quality 2026-07-05T22:50:19.269Z monthly 0.5 https://novapharmanews.com/apac/news/huahui-health-beone-medicines-hh160-trispecific-antibody-oncology-partnership 2026-07-06T06:27:35.241Z monthly 0.5 https://novapharmanews.com/apac/news/amgen-q1-2026-financial-results-double-digit-growth 2026-07-06T07:25:25.383Z monthly 0.5 https://novapharmanews.com/apac/news/haier-biomedical-international-revenue-growth-2025 2026-07-05T09:59:51.196Z monthly 0.5 https://novapharmanews.com/apac/news/tga-combination-boundary-products-guidance-apac-pharmaceutical 2026-07-05T14:19:39.930Z monthly 0.5 https://novapharmanews.com/apac/news/genprex-israel-patent-reqorsa-gene-therapy-pd1-antibodies-cancer 2026-07-05T16:32:08.581Z monthly 0.5 https://novapharmanews.com/apac/news/prolacta-human-milk-fortifiers-prescription-drug-status-japan-jasmine-trial 2026-07-04T21:51:50.851Z monthly 0.5 https://novapharmanews.com/eu/news/stoke-therapeutics-zorevunersen-dravet-syndrome-q1-2026-results 2026-07-06T06:37:18.281Z monthly 0.5 https://novapharmanews.com/eu/news/uniqure-amt-130-gene-therapy-uk-approval-huntingtons-disease 2026-07-05T17:34:52.361Z monthly 0.5 https://novapharmanews.com/eu/news/northwest-biotherapeutics-annalisa-jenkins-dcvax-cancer-vaccine-adviser 2026-07-04T21:49:30.055Z monthly 0.5 https://novapharmanews.com/eu/news/cerus-intercept-blood-system-european-regulatory-review-phase-3-trials 2026-07-06T02:54:36.796Z monthly 0.5 https://novapharmanews.com/eu/news/bio-rad-q1-2026-ivdr-compliance-costs-european-diagnostics 2026-07-06T08:37:04.567Z monthly 0.5 https://novapharmanews.com/eu/news/alkeus-gildeuretinol-stargardt-disease-arvo-2026-data 2026-07-06T14:17:44.623Z monthly 0.5 https://novapharmanews.com/eu/news/setpoint-medical-multiple-sclerosis-trial-neuroimmune-therapy 2026-07-06T12:49:23.112Z monthly 0.5 https://novapharmanews.com/eu/news/emergent-biosolutions-q1-2026-financial-results 2026-07-06T17:29:42.390Z monthly 0.5 https://novapharmanews.com/eu/news/telix-tlx101-px-pixlumi-brain-cancer-imaging-european-approval 2026-07-06T12:17:49.688Z monthly 0.5 https://novapharmanews.com/us/news/mrm-health-mh002-fda-fast-track-ulcerative-colitis 2026-07-04T18:13:02.645Z monthly 0.5 https://novapharmanews.com/us/news/cadrenal-therapeutics-cad-1005-fda-phase-3-heparin-induced-thrombocytopenia 2026-07-06T11:34:47.110Z monthly 0.5 https://novapharmanews.com/us/news/redhill-rhb-204-comparable-efficacy-rhb-104-crohns-disease-map-treatment 2026-07-05T15:24:35.029Z monthly 0.5 https://novapharmanews.com/us/news/phathom-pharmaceuticals-voquezna-q1-2026-earnings-profitability-guidance 2026-07-06T06:56:24.036Z monthly 0.5 https://novapharmanews.com/us/news/contineum-therapeutics-pipe-791-positive-phase-1b-chronic-pain-results 2026-07-06T13:34:10.448Z monthly 0.5 https://novapharmanews.com/us/news/summit-therapeutics-ivonescimab-overall-survival-lung-cancer-asco-2026 2026-07-06T18:09:20.126Z monthly 0.5 https://novapharmanews.com/us/news/ac-immune-aci-24-alzheimers-trial-final-cohort-aci-19764-phase-1 2026-07-06T10:21:43.540Z monthly 0.5 https://novapharmanews.com/us/news/addex-dipraglurant-brain-injury-recovery-2025-results 2026-07-05T22:47:13.732Z monthly 0.5 https://novapharmanews.com/us/news/ac-immune-final-cohort-abate-trial-anti-abeta-alzheimer-treatment 2026-07-04T10:38:23.515Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-cervical-cancer-esmo-gc-2026 2026-07-05T02:08:33.747Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-securities-fraud-lawsuit-anaphylm-fda-review 2026-07-06T12:39:36.307Z monthly 0.5 https://novapharmanews.com/us/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-07-02T19:53:59.762Z monthly 0.5 https://novapharmanews.com/us/news/eli-lilly-foundayo-orforglipron-fda-approval-obesity-q1-2026-results 2026-07-06T17:06:12.691Z monthly 0.5 https://novapharmanews.com/us/news/theradaptive-fda-approval-osteoadapt-sp-phase-3-spinal-fusion-trial 2026-07-05T21:49:50.760Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-ai-gene-therapy 2026-07-06T18:05:43.241Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-q1-2026-licensing-deals 2026-07-06T17:50:40.616Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-ai-oncology-preview 2026-07-06T15:10:45.771Z monthly 0.5 https://novapharmanews.com/us/news/ipec-excipient-world-biologics-summit-2026-preview 2026-07-06T18:15:50.893Z monthly 0.5 https://novapharmanews.com/apac/news/axoft-55m-series-a-brain-computer-interface-clinical-trials 2026-07-06T17:54:13.550Z monthly 0.5 https://novapharmanews.com/apac/news/vivacta-bio-50-million-series-a-funding-gt801-car-t-therapy 2026-07-06T16:02:18.897Z monthly 0.5 https://novapharmanews.com/apac/news/taimei-technology-ai-clinical-trials-biokorea-2026 2026-07-06T18:28:34.282Z monthly 0.5 https://novapharmanews.com/apac/news/energenesis-energi-f703dfu-diabetic-foot-ulcer-ewma-2026 2026-07-06T00:05:48.885Z monthly 0.5 https://novapharmanews.com/apac/news/ascletis-pharma-diabetes-drug-data-ada-2026-scientific-sessions 2026-07-05T05:33:17.769Z monthly 0.5 https://novapharmanews.com/apac/news/tlx597-tx-psma-radioligand-therapy-optimal-trial-prostate-cancer 2026-07-06T15:44:14.550Z monthly 0.5 https://novapharmanews.com/apac/news/immunitybio-securities-fraud-lawsuit-anktiva-fda-warning-letter 2026-07-06T15:25:00.255Z monthly 0.5 https://novapharmanews.com/eu/news/hutchmed-sovleplenib-priority-review-breakthrough-designation-china-autoimmune-hemolytic-anemia 2026-07-06T00:44:09.899Z monthly 0.5 https://novapharmanews.com/eu/news/fda-real-world-evidence-framework-medtech-ventripoint-10-billion 2026-07-05T15:12:11.368Z monthly 0.5 https://novapharmanews.com/us/news/purespring-therapeutics-nphs2-genetic-variants-adult-onset-fsgs-study 2026-07-05T04:41:37.942Z monthly 0.5 https://novapharmanews.com/us/news/viking-therapeutics-vk2735-phase-3-obesity-trials-enrolled-q1-2026 2026-07-06T17:16:20.648Z monthly 0.5 https://novapharmanews.com/us/news/relay-therapeutics-q1-2026-earnings-zovegalisib-updates-may-5 2026-07-05T07:54:46.527Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-ingrezza-tardive-dyskinesia-improvement-threshold-study 2026-07-05T23:55:39.639Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-denecimig-hemophilia-a-phase-3-trial-nejm 2026-07-06T09:09:40.613Z monthly 0.5 https://novapharmanews.com/us/news/addex-gabab-pam-ipf-chronic-cough-preclinical-results 2026-07-06T06:49:14.574Z monthly 0.5 https://novapharmanews.com/us/news/iga-nephropathy-market-forecast-2036-novartis-zigakibart-immunotherapies 2026-07-06T10:16:15.125Z monthly 0.5 https://novapharmanews.com/us/news/perimeter-medical-claire-oct-ai-fda-approval-breast-cancer-surgery 2026-07-05T22:50:37.486Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-q1-2026-earnings-dupixent-eylea-hd-sales-growth 2026-07-06T18:08:17.920Z monthly 0.5 https://novapharmanews.com/us/news/sprout-pharmaceuticals-addyi-flibanserin-time-top-10-influential-health-companies-2026 2026-07-06T03:48:59.650Z monthly 0.5 https://novapharmanews.com/eu/news/biopharma-clinical-trials-eu-daily-insights 2026-07-06T13:45:54.694Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-2026-key-takeaways 2026-07-06T18:05:31.241Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026-key-takeaways 2026-07-06T16:31:11.880Z monthly 0.5 https://novapharmanews.com/us/news/ieee-cog-2026-industry-day-game-dev-tutorials 2026-07-06T09:17:48.814Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-highlights 2026-07-06T10:25:37.328Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-apac 2026-07-06T11:49:49.544Z monthly 0.5 https://novapharmanews.com/apac/news/insilico-rentosertib-inhalation-ind-clearance-ai-drug-clinical-trial 2026-07-06T17:02:58.230Z monthly 0.5 https://novapharmanews.com/apac/news/thailand-asean-medical-device-market-gateway-2029 2026-07-06T17:38:40.241Z monthly 0.5 https://novapharmanews.com/apac/news/yangtze-river-pharmaceutical-group-international-revenue-growth-2025 2026-07-06T16:12:45.431Z monthly 0.5 https://novapharmanews.com/apac/news/soleno-therapeutics-securities-fraud-lawsuit-phase-3-clinical-trials 2026-07-05T09:44:52.829Z monthly 0.5 https://novapharmanews.com/apac/news/newleos-ntx-2001-phase-1b-trial-alcohol-use-disorder 2026-07-06T06:19:44.995Z monthly 0.5 https://novapharmanews.com/apac/news/citius-oncology-lymphir-first-international-shipment-europe 2026-07-06T18:26:29.377Z monthly 0.5 https://novapharmanews.com/apac/news/eirgenix-japan-biosimilar-expansion-cphi-2026 2026-07-06T15:03:51.600Z monthly 0.5 https://novapharmanews.com/eu/news/european-commission-approves-poherdy-pertuzumab-biosimilar-henlius-organon 2026-07-06T12:25:15.059Z monthly 0.5 https://novapharmanews.com/eu/news/puretech-lyt-200-clinical-results-myeloid-malignancies-2025 2026-07-05T06:47:10.668Z monthly 0.5 https://novapharmanews.com/eu/news/enterobiotix-19m-funding-phase-2b-ibs-microbiome-trial 2026-07-06T12:24:58.261Z monthly 0.5 https://novapharmanews.com/eu/news/ray-therapeutics-rtx-015-ema-prime-designation-retinitis-pigmentosa 2026-07-06T16:02:52.491Z monthly 0.5 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-european-approval-whim-syndrome-treatment 2026-07-06T10:42:27.012Z monthly 0.5 https://novapharmanews.com/eu/news/ema-expert-panel-covid-19-mrna-vaccine-trust-spikevax-comirnaty 2026-07-06T03:49:24.253Z monthly 0.5 https://novapharmanews.com/eu/news/henlius-organon-poherdy-first-pertuzumab-biosimilar-approved-europe 2026-07-06T03:43:38.817Z monthly 0.5 https://novapharmanews.com/us/news/fda-clinical-hold-newron-evenamide-phase-3-trial-treatment-resistant-schizophrenia 2026-07-06T17:25:35.933Z monthly 0.5 https://novapharmanews.com/us/news/teva-q1-2026-results-ponlimsi-fda-approval-olanzapine-lai 2026-07-06T03:26:45.018Z monthly 0.5 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug 2026-07-06T17:29:25.442Z monthly 0.5 https://novapharmanews.com/us/news/teva-ponlimsi-biosimilar-fda-approval-prolia-q1-2026-results 2026-07-06T18:21:36.463Z monthly 0.5 https://novapharmanews.com/us/news/bayer-asundexian-stroke-trial-esoc-2026-abstracts 2026-07-06T16:12:58.646Z monthly 0.5 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-multiple-myeloma-isct-2026 2026-07-06T02:38:52.020Z monthly 0.5 https://novapharmanews.com/us/news/pfizer-elrexfio-progression-free-survival-multiple-myeloma-phase-3-trial 2026-07-06T16:49:55.318Z monthly 0.5 https://novapharmanews.com/us/news/rein-therapeutics-lti-03-phase-2-trial-enrollment-update-ipf 2026-07-06T05:56:12.204Z monthly 0.5 https://novapharmanews.com/us/news/laguna-biotherapeutics-fda-clearance-lgna-100-pediatric-leukemia-trial 2026-07-06T15:32:58.136Z monthly 0.5 https://novapharmanews.com/us/news/expression-therapeutics-fda-fast-track-hemophilia-a-stem-cell-therapy 2026-07-04T21:44:15.493Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-gilead-bictegravir-lenacapavir-hiv-treatment 2026-07-06T09:13:55.896Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-otarmeni-gene-therapy-free-hearing-loss-government-agreement 2026-07-06T09:09:57.515Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals 2026-07-06T15:13:50.100Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-daily-highlights 2026-07-05T12:49:32.414Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-investment 2026-07-06T18:13:08.156Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-oncology-data-readouts 2026-07-06T18:19:30.574Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-oncology-trials-preview 2026-07-06T09:30:19.002Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-day-1 2026-07-05T10:02:20.023Z monthly 0.5 https://novapharmanews.com/apac/news/trialcliniq-150k-investment-caduceus-capital-ai-clinical-trial-recruitment 2026-07-04T06:39:41.596Z monthly 0.5 https://novapharmanews.com/apac/news/argo-biopharma-bw-50218-phase-1-trial-first-patient-sirna-therapy 2026-07-06T09:03:51.657Z monthly 0.5 https://novapharmanews.com/apac/news/claruvis-retoxin-first-recombinant-botulinum-toxin-approval-china 2026-07-06T18:32:48.721Z monthly 0.5 https://novapharmanews.com/apac/news/jyong-biotech-botreso-botanical-drug-market-access-strategy-2026 2026-07-06T09:37:56.601Z monthly 0.5 https://novapharmanews.com/apac/news/arcera-life-sciences-fosun-pharma-neurodegenerative-disease-collaboration 2026-07-05T22:13:05.422Z monthly 0.5 https://novapharmanews.com/apac/news/samsung-bioepis-atlatl-partnership-asia-pacific-biotech-innovation 2026-07-06T13:08:07.159Z monthly 0.5 https://novapharmanews.com/apac/news/tga-implantable-medical-devices-regulatory-framework-australia-2024 2026-07-05T07:26:29.245Z monthly 0.5 https://novapharmanews.com/apac/news/immunic-appoints-michael-panzara-chief-medical-officer-vidofludimus-calcium 2026-07-06T06:59:58.467Z monthly 0.5 https://novapharmanews.com/apac/news/zhengye-biotechnology-fiscal-2025-financial-results-veterinary-vaccines 2026-07-04T16:30:00.056Z monthly 0.5 https://novapharmanews.com/eu/news/vivosim-labs-ai-tool-predicts-drug-diarrhea-without-animal-testing 2026-07-03T05:40:51.663Z monthly 0.5 https://novapharmanews.com/eu/news/boehringer-ingelheim-survodutide-weight-loss-phase-2-trial-results 2026-07-03T07:51:16.504Z monthly 0.5 https://novapharmanews.com/eu/news/idorsia-quviviq-74-percent-sales-growth-q1-2026-european-expansion 2026-07-06T14:09:49.614Z monthly 0.5 https://novapharmanews.com/eu/news/small-molecule-api-market-202-billion-2036-generic-drugs 2026-07-06T13:04:21.831Z monthly 0.5 https://novapharmanews.com/eu/news/silexion-therapeutics-sil204-phase-2-3-trial-kras-pancreatic-cancer 2026-07-06T13:05:12.466Z monthly 0.5 https://novapharmanews.com/eu/news/novo-nordisk-wegovy-data-women-obesity-european-congress-2026 2026-07-05T16:25:11.341Z monthly 0.5 https://novapharmanews.com/eu/news/solid-biosciences-sgt-003-european-orphan-drug-designation-duchenne-muscular-dystrophy 2026-07-06T08:24:50.877Z monthly 0.5 https://novapharmanews.com/eu/news/cytokinetics-myqorzo-aficamten-esc-heart-failure-2026-congress 2026-07-05T21:13:49.740Z monthly 0.5 https://novapharmanews.com/eu/news/artiva-biotherapeutics-allonk-fda-fast-track-rheumatoid-arthritis 2026-07-02T22:02:55.732Z monthly 0.5 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-ce-marking-approval-european-market 2026-07-05T23:15:00.834Z monthly 0.5 https://novapharmanews.com/us/news/aop-health-rapiblyk-landiolol-first-patient-treatment-us 2026-07-06T14:55:19.041Z monthly 0.5 https://novapharmanews.com/us/news/emergent-biosolutions-substipharm-japanese-encephalitis-vaccine-manufacturing-partnership 2026-07-04T01:50:10.924Z monthly 0.5 https://novapharmanews.com/us/news/zealand-pharma-survodutide-weight-loss-phase-3-trial-results 2026-07-06T18:09:06.842Z monthly 0.5 https://novapharmanews.com/us/news/ashvattha-therapeutics-migaldendranib-diabetic-macular-edema-amd-data 2026-07-06T12:04:23.622Z monthly 0.5 https://novapharmanews.com/us/news/aclaris-ati-052-phase-1a-trial-results-45-day-half-life 2026-07-06T13:57:30.020Z monthly 0.5 https://novapharmanews.com/us/news/trevi-therapeutics-q1-2026-earnings-haduvio-chronic-cough-updates 2026-07-06T11:10:13.193Z monthly 0.5 https://novapharmanews.com/us/news/soligenix-hybryte-phase-3-flash2-trial-interim-results-ctcl 2026-07-06T18:05:11.984Z monthly 0.5 https://novapharmanews.com/us/news/avicanna-us-cannabis-rescheduling-medical-research-development 2026-06-23T03:54:10.833Z monthly 0.5 https://novapharmanews.com/us/news/innocare-orelabrutinib-phase-3-trial-sle-treatment 2026-07-06T09:42:29.797Z monthly 0.5 https://novapharmanews.com/us/news/orca-bio-orca-q-fda-rmat-designation-blood-cancers 2026-07-06T13:49:52.406Z monthly 0.5 https://novapharmanews.com/us/news/formblends-2026-peptide-report-rfk-hhs-glp1-therapy-access 2026-07-06T06:37:12.680Z monthly 0.5 https://novapharmanews.com/us/news/c-ray-therapeutics-fda-copper-64-drug-master-file-approval 2026-07-06T06:43:08.385Z monthly 0.5 https://novapharmanews.com/us/news/brc-therapeutics-fda-clearance-brc-002-phase-1-trial-crps 2026-07-06T18:06:11.491Z monthly 0.5 https://novapharmanews.com/us/news/vanda-pharmaceuticals-imsidolimab-generalized-pustular-psoriasis-nejm-evidence 2026-07-06T15:37:59.818Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-breztri-aerosphere-approved-first-triple-therapy-asthma-patients-12-older 2026-07-06T09:16:39.817Z monthly 0.5 https://novapharmanews.com/us/news/vensica-medical-fda-ind-approval-vixe-xeomin-needle-free-delivery-overactive-bladder 2026-07-06T07:29:10.716Z monthly 0.5 https://novapharmanews.com/us/news/abbvie-upadacitinib-rinvoq-fda-application-alopecia-areata 2026-07-06T18:00:08.887Z monthly 0.5 https://novapharmanews.com/us/news/novartis-q1-2026-earnings-remibrutinib-chmp-approval-pipeline-growth 2026-07-06T17:26:16.133Z monthly 0.5 https://novapharmanews.com/us/news/wave-life-sciences-wve-007-phase-2a-fda-approval-obesity-diabetes 2026-07-06T12:59:22.073Z monthly 0.5 https://novapharmanews.com/eu/news/biopharma-clinical-trials-daily-roundup 2026-07-06T06:58:17.142Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-emergent-evolveimmune-deals 2026-07-05T21:58:46.421Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-deal-surge-lilly-sun 2026-07-05T06:15:43.885Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-investment-trends 2026-07-06T04:13:49.701Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-annex-1-challenges 2026-07-06T17:08:31.970Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-day-1-highlights 2026-07-06T06:51:15.905Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-event-day-1 2026-07-06T14:11:37.331Z monthly 0.5 https://novapharmanews.com/us/news/ascrs-2026-opus-genetics-phentolamine-preview 2026-07-06T14:16:58.731Z monthly 0.5 https://novapharmanews.com/us/news/fdli-2026-fda-strategic-priorities 2026-07-06T17:24:04.551Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-day-1-roundup 2026-07-06T10:40:08.965Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-2026-daily-roundup 2026-07-06T07:51:17.709Z monthly 0.5 https://novapharmanews.com/apac/news/akso-health-group-brain-computer-interface-rd-program-neurotechnology 2026-07-06T02:13:48.478Z monthly 0.5 https://novapharmanews.com/apac/news/evofem-solosec-distribution-agreement-sub-saharan-africa 2026-07-05T17:28:35.788Z monthly 0.5 https://novapharmanews.com/apac/news/psg-2026-specialty-drug-benefits-report-cost-management-coverage-strategies 2026-07-05T15:28:01.612Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-apptec-q1-2026-revenue-growth-backlog-results 2026-07-06T08:10:44.160Z monthly 0.5 https://novapharmanews.com/apac/news/img-pharma-acquires-matsumoto-pharmaceutical-japan-expansion 2026-07-06T14:15:28.153Z monthly 0.5 https://novapharmanews.com/apac/news/aquestive-therapeutics-anaphylm-class-action-lawsuit-approval-timeline 2026-07-05T10:18:47.981Z monthly 0.5 https://novapharmanews.com/apac/news/biomarin-completes-amicus-therapeutics-acquisition-galafold-pompe-therapies 2026-07-05T20:59:54.294Z monthly 0.5 https://novapharmanews.com/eu/news/elanco-negasunt-tanidil-emergency-authorization-screwworm-livestock 2026-07-06T00:55:11.981Z monthly 0.5 https://novapharmanews.com/eu/news/opella-essentiale-excel-trial-fatty-liver-disease-masld-results 2026-07-06T08:14:17.674Z monthly 0.5 https://novapharmanews.com/eu/news/advanced-bifurcation-systems-acquires-svelte-medical-coronary-stent-deal 2026-07-06T17:34:22.266Z monthly 0.5 https://novapharmanews.com/eu/news/zentiva-appeals-eu-court-urban-wastewater-directive-generic-medicines 2026-07-06T08:07:22.819Z monthly 0.5 https://novapharmanews.com/eu/news/ab-science-loan-repayment-deferral-agreement-2026 2026-07-04T20:27:47.655Z monthly 0.5 https://novapharmanews.com/eu/news/mundipharma-rezzayo-rezafungin-phase-iii-respect-trial-results-fungal-disease-prevention 2026-07-03T18:27:19.369Z monthly 0.5 https://novapharmanews.com/eu/news/crinetics-palsonify-paltusotine-eu-approval-acromegaly-treatment 2026-07-06T15:25:26.474Z monthly 0.5 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0801-phase-2-aplastic-anemia-trial 2026-07-05T22:47:09.635Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-saphnelo-autoinjector-fda-approved-lupus-self-administration 2026-07-06T03:19:05.133Z monthly 0.5 https://novapharmanews.com/us/news/dmx-200-action3-trial-statistical-power-blinded-review 2026-07-06T18:29:56.910Z monthly 0.5 https://novapharmanews.com/us/news/concept-medical-sirona-trial-3-year-data-charing-cross-2026 2026-07-05T19:57:00.511Z monthly 0.5 https://novapharmanews.com/us/news/intellia-lonvo-z-fda-submission-crispr-hereditary-angioedema 2026-07-06T17:23:44.853Z monthly 0.5 https://novapharmanews.com/us/news/cordis-selution-slr-drug-eluting-balloon-japan-launch-2026 2026-07-06T17:44:59.456Z monthly 0.5 https://novapharmanews.com/us/news/tovecimig-biliary-tract-cancer-trial-results-companion-002 2026-07-06T15:09:25.560Z monthly 0.5 https://novapharmanews.com/us/news/intellia-lonvoguran-ziclumeran-phase-3-hereditary-angioedema-gene-editing 2026-07-06T17:32:49.313Z monthly 0.5 https://novapharmanews.com/us/news/sagimet-biosciences-denifanstat-phase-3-acne-trial-2026 2026-07-06T18:02:01.912Z monthly 0.5 https://novapharmanews.com/us/news/apollomics-vebreltinib-phase-2-3-ind-submission-nsclc-treatment 2026-07-06T09:29:05.275Z monthly 0.5 https://novapharmanews.com/us/news/aclaris-therapeutics-ati-052-phase-1a-results-ati-2138-update-april-2026 2026-07-06T04:58:22.368Z monthly 0.5 https://novapharmanews.com/us/news/ose-immunotherapeutics-pegrizeprument-vel-101-fda-orphan-drug-designation-heart-transplant 2026-07-06T12:19:29.990Z monthly 0.5 https://novapharmanews.com/us/news/jazz-pharmaceuticals-ziihera-fda-priority-review-her2-cancer 2026-07-06T17:07:19.076Z monthly 0.5 https://novapharmanews.com/us/news/nccn-adds-nuvation-bio-taletrectinib-ibtrozi-cancer-guidelines-ros1-nsclc-brain-metastases 2026-07-06T16:51:04.922Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-imaavy-nipocalimab-warm-autoimmune-hemolytic-anemia 2026-07-05T16:39:25.545Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-caplyta-lumateperone-snda-schizophrenia-relapse-prevention 2026-07-06T14:49:07.844Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-pharma-news-roundup-april-28-2026 2026-07-06T10:11:42.265Z monthly 0.5 https://novapharmanews.com/us/news/4th-annual-cog-2026-no-pharma-news 2026-07-06T14:13:05.445Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-day-1-roundup 2026-07-05T03:57:13.786Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-patient-centric-trials-workforce 2026-07-06T07:58:37.721Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-regulatory-updates-day-1 2026-07-05T07:15:37.125Z monthly 0.5 https://novapharmanews.com/us/news/testosterone-therapy-fda-update-regulatory-advances 2026-07-05T15:11:43.677Z monthly 0.5 https://novapharmanews.com/us/news/glp-1-eating-disorder-risk-true-facts 2026-07-06T18:01:53.074Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-ai-pathology-oncolytic-virus 2026-07-06T03:07:11.814Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-phillips-medisize-sensing 2026-07-06T17:23:44.189Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-ai-patient-centricity 2026-07-06T13:57:16.241Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-biopharma-medtech-highlights 2026-07-06T16:17:54.590Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-funding-dealmaking-highlights 2026-07-06T15:59:17.411Z monthly 0.5 https://novapharmanews.com/eu/news/asco-2026-olverembatinib-gastric-cancer-trials 2026-07-06T15:34:27.558Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-sustainability-2026-packaging-preview 2026-07-06T17:13:20.491Z monthly 0.5 https://novapharmanews.com/apac/news/eyebright-medical-2025-annual-report-sustainability-results 2026-07-06T17:58:22.135Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-japanese-pharmacopoeia-medical-device-standards-regulatory-science 2026-07-04T23:01:18.781Z monthly 0.5 https://novapharmanews.com/eu/news/boston-scientific-securities-class-action-lawsuit-may-2026 2026-07-06T15:18:32.244Z monthly 0.5 https://novapharmanews.com/eu/news/brii-bio-elebsiran-hepatitis-b-control-apasl-2026-analysis 2026-07-06T16:47:09.510Z monthly 0.5 https://novapharmanews.com/us/news/ascletis-asc30-oral-glp-1-diabetes-phase-2-trial-enrollment-complete 2026-07-06T11:48:27.067Z monthly 0.5 https://novapharmanews.com/us/news/ascletis-asc30-phase-ii-enrollment-complete-oral-glp1-diabetes 2026-07-06T11:49:36.783Z monthly 0.5 https://novapharmanews.com/us/news/sun-pharma-acquires-organon-11-75-billion-merger-2026 2026-07-06T17:15:44.176Z monthly 0.5 https://novapharmanews.com/us/news/boston-scientific-farapulse-watchman-heart-rhythm-2026-data 2026-07-06T14:52:35.153Z monthly 0.5 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-male-pattern-hair-loss 2026-07-04T23:00:42.192Z monthly 0.5 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-conference-call 2026-07-06T17:11:13.474Z monthly 0.5 https://novapharmanews.com/us/news/adagio-medical-vclas-ventricular-ablation-system-pivotal-trial-results 2026-07-06T15:49:05.975Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-opens 2026-07-06T15:32:35.650Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-daily-roundup 2026-07-06T13:53:38.082Z monthly 0.5 https://novapharmanews.com/apac/news/pmc-organometallix-price-increase-all-products-may-2026 2026-07-03T11:43:07.499Z monthly 0.5 https://novapharmanews.com/apac/news/tga-personalised-medical-device-regulations-guidance-2024 2026-07-06T13:00:21.030Z monthly 0.5 https://novapharmanews.com/us/news/atara-biotherapeutics-securities-class-action-lawsuit-may-2026-deadline 2026-07-05T21:06:37.755Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-class-action-lawsuit-fda-application 2026-07-05T20:23:46.656Z monthly 0.5 https://novapharmanews.com/us/news/pulse-biosciences-npulse-cardiac-catheter-heart-rhythm-2026-trial-data 2026-07-04T21:51:34.754Z monthly 0.5 https://novapharmanews.com/us/news/abbott-tactiflex-duo-ablation-catheter-afib-results-hrs-2026 2026-07-06T15:33:33.560Z monthly 0.5 https://novapharmanews.com/us/news/medtronic-affera-sphere-9-catheter-fda-breakthrough-device-designation-ventricular-tachycardia 2026-07-06T17:23:16.386Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-rexatilux-ranibizumab-eye-treatment 2026-07-06T08:38:43.852Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-redemplo-plozasiran-european-approval 2026-07-05T06:41:47.374Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-viatris-palbociclib-generic-cancer-treatment 2026-07-06T07:02:14.938Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-itvisma-onasemnogene-abeparvovec-sma-gene-therapy 2026-07-06T13:56:54.491Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-cenrifki-tolebrutinib-multiple-sclerosis 2026-07-06T04:46:06.032Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-first-rna-veterinary-vaccine-nobivac-nxt-cats 2026-07-06T05:29:52.437Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-plozasiran-redemplo-familial-chylomicronaemia-syndrome-fcs 2026-07-05T23:08:41.961Z monthly 0.5 https://novapharmanews.com/eu/news/ema-chmp-recommends-tolebrutinib-cenrifki-five-medicines-approval-april-2026 2026-07-06T14:55:21.328Z monthly 0.5 https://novapharmanews.com/us/news/fda-gdufa-generic-drug-user-fee-amendments-2024-updates 2026-07-06T12:55:45.108Z monthly 0.5 https://novapharmanews.com/us/news/fda-omufa-user-fee-program-otc-monograph-drugs 2026-07-06T08:59:36.185Z monthly 0.5 https://novapharmanews.com/us/news/fda-gdufa-iv-reauthorization-2028-2032-generic-drug-user-fees 2026-07-06T04:30:07.834Z monthly 0.5 https://novapharmanews.com/us/news/fda-testosterone-therapy-low-libido-hypogonadism-2024 2026-07-06T08:55:48.266Z monthly 0.5 https://novapharmanews.com/us/news/fda-reduces-animal-testing-drug-development-alternatives-2024 2026-07-06T18:29:46.764Z monthly 0.5 https://novapharmanews.com/us/news/cms-fda-rapid-coverage-pathway-breakthrough-medical-devices-medicare 2026-07-06T18:03:57.258Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-otarmeni-first-gene-therapy-genetic-hearing-loss 2026-07-06T00:13:38.471Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerates-mental-health-treatment-access-executive-order 2026-07-05T17:37:54.225Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-day-1-roundup 2026-07-06T04:16:49.690Z monthly 0.5 https://novapharmanews.com/us/news/scope-x-2026-clinical-ops-data-ai-boston 2026-07-06T03:27:46.564Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-clinical-trial-innovation 2026-07-06T09:09:11.697Z monthly 0.5 https://novapharmanews.com/apac/news/sunnybrook-41-million-investment-clinical-trials-canada 2026-07-06T02:26:47.362Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-chengdu-microbial-manufacturing-completion-2026 2026-07-06T14:04:28.788Z monthly 0.5 https://novapharmanews.com/apac/news/quasar-medical-thailand-manufacturing-facility-medtech-expansion 2026-07-06T11:40:56.236Z monthly 0.5 https://novapharmanews.com/apac/news/daewoong-nabota-master-class-prabotulinumtoxina-safety-2026 2026-07-06T06:09:37.216Z monthly 0.5 https://novapharmanews.com/apac/news/amcor-35m-healthcare-packaging-facility-malaysia-medical-supply-chain 2026-07-06T15:54:09.315Z monthly 0.5 https://novapharmanews.com/apac/news/transcarent-smithrx-partnership-pharmacy-benefits-platform 2026-07-05T22:34:12.072Z monthly 0.5 https://novapharmanews.com/apac/news/hanchorbio-bloomberg-partnership-drug-development-intelligence 2026-07-05T01:16:34.694Z monthly 0.5 https://novapharmanews.com/eu/news/aetna-prior-authorization-reform-88-percent-standardized-2026 2026-07-06T12:00:02.479Z monthly 0.5 https://novapharmanews.com/eu/news/guerbet-lipiodol-ultra-fluid-eu-approval-vascular-embolization 2026-07-06T03:27:27.236Z monthly 0.5 https://novapharmanews.com/eu/news/rna-therapy-clinical-trials-market-3-4-billion-2035-forecast 2026-07-06T14:18:15.990Z monthly 0.5 https://novapharmanews.com/eu/news/oncotelic-therapeutics-partnership-strategy-update-2026 2026-07-06T15:28:57.660Z monthly 0.5 https://novapharmanews.com/eu/news/clinuvel-scenesse-phase-iii-vitiligo-trial-ema-approval-2026 2026-07-06T15:12:00.865Z monthly 0.5 https://novapharmanews.com/us/news/frankfurt-court-upholds-besremi-arbitral-award-aop-health-pharmaessentia 2026-07-05T21:10:12.550Z monthly 0.5 https://novapharmanews.com/us/news/novartis-coartem-baby-who-prequalification-malaria-treatment-newborns 2026-07-06T12:40:25.878Z monthly 0.5 https://novapharmanews.com/us/news/miracell-smart-m-cell-alzheimers-stem-cell-therapy-results 2026-07-06T08:46:22.281Z monthly 0.5 https://novapharmanews.com/us/news/berlin-heals-positive-cmic-iii-heart-failure-device-results 2026-07-05T04:06:34.554Z monthly 0.5 https://novapharmanews.com/us/news/citius-pharmaceuticals-5-million-direct-offering-stock-nasdaq 2026-07-06T13:43:29.831Z monthly 0.5 https://novapharmanews.com/us/news/haemonetics-vascade-mvp-xl-safety-efficacy-study-large-bore-venous-closure 2026-07-05T23:58:41.747Z monthly 0.5 https://novapharmanews.com/us/news/briohealth-solutions-fda-approval-pediatric-briovad-heart-device-trial 2026-07-06T06:40:40.082Z monthly 0.5 https://novapharmanews.com/us/news/cgbio-fda-clearance-easymade-ti-titanium-implant 2026-07-04T13:58:54.249Z monthly 0.5 https://novapharmanews.com/us/news/cerapedics-vizient-supplier-agreement-pearlmatrix-p15-bone-graft 2026-07-05T13:51:45.821Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-day-1 2026-07-06T10:57:03.328Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-daily-roundup 2026-06-23T16:00:48.692Z monthly 0.5 https://novapharmanews.com/apac/news/catalym-visugromab-phase-2-3-trial-cancer-cachexia-first-patient-dosed 2026-07-06T10:06:39.668Z monthly 0.5 https://novapharmanews.com/apac/news/spinogenix-spg601-clarity-trial-fragile-x-syndrome-phase-2b-3 2026-07-06T18:26:40.248Z monthly 0.5 https://novapharmanews.com/apac/news/tga-biologicals-regulatory-framework-advanced-therapies-australia 2026-07-05T20:25:35.393Z monthly 0.5 https://novapharmanews.com/eu/news/renovorx-tamp-therapy-asco-2026-tiger-pac-trial-data 2026-07-05T12:26:51.826Z monthly 0.5 https://novapharmanews.com/eu/news/genomics-services-market-24-billion-2033-precision-medicine 2026-07-05T19:25:45.350Z monthly 0.5 https://novapharmanews.com/eu/news/accenture-invests-iridius-ai-compliance-life-sciences 2026-07-05T14:08:55.551Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-q1-2026-sales-growth-momentum 2026-07-06T07:28:48.145Z monthly 0.5 https://novapharmanews.com/eu/news/cumberland-pharmaceuticals-apotex-strategic-integration-partnership 2026-07-06T09:20:46.003Z monthly 0.5 https://novapharmanews.com/us/news/cortec-brain-interchange-bci-fda-tap-program-stroke-rehabilitation 2026-07-06T15:52:59.168Z monthly 0.5 https://novapharmanews.com/us/news/tivic-health-rebrands-valion-bio-entolimod-acute-radiation-syndrome-fda-fast-track 2026-07-05T20:45:25.610Z monthly 0.5 https://novapharmanews.com/us/news/edwards-lifesciences-q1-2026-results-tmtt-sales-guidance-raise 2026-07-06T13:34:47.201Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-class-action-lawsuit-anktiva 2026-07-06T17:56:31.519Z monthly 0.5 https://novapharmanews.com/us/news/transmedics-chops-organ-preservation-system-ishlt-2026 2026-07-06T14:59:59.395Z monthly 0.5 https://novapharmanews.com/us/news/abbvie-fda-complete-response-letter-trenibotulinumtoxine-trenibote-manufacturing 2026-07-05T09:42:37.328Z monthly 0.5 https://novapharmanews.com/us/news/alpha-tau-fda-approval-alpha-dart-pancreatic-cancer-trial-expansion 2026-07-02T20:05:06.290Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-regeneron-otarmeni-gene-therapy-genetic-hearing-loss 2026-07-05T10:38:50.266Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-parexel-hiring 2026-07-06T17:24:25.934Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day1-roundup 2026-07-03T16:38:57.451Z monthly 0.5 https://novapharmanews.com/us/news/generic-drug-forum-2026-highlights 2026-07-06T17:00:39.135Z monthly 0.5 https://novapharmanews.com/eu/news/tilray-brands-us-medical-cannabis-expansion-rescheduling-2026 2026-07-03T15:25:52.252Z monthly 0.5 https://novapharmanews.com/us/news/capricor-therapeutics-hope-3-phase-3-deramiocel-duchenne-muscular-dystrophy-aan-2026 2026-07-06T16:30:57.798Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-event-pharma-ai-future 2026-07-05T13:57:36.987Z monthly 0.5 https://novapharmanews.com/apac/news/samsung-bioepis-sbe303-phase-1-trial-sandoz-partnership-2026 2026-07-06T14:39:51.181Z monthly 0.5 https://novapharmanews.com/apac/news/fosun-health-wins-awards-globalhealth-asia-pacific-forum-2026 2026-07-06T03:28:11.938Z monthly 0.5 https://novapharmanews.com/apac/news/minjuvi-tafasitamab-approved-australia-follicular-lymphoma 2026-07-05T09:00:02.987Z monthly 0.5 https://novapharmanews.com/eu/news/ccbd-car-t-cell-therapy-maryland-community-oncology 2026-07-06T15:58:16.643Z monthly 0.5 https://novapharmanews.com/eu/news/samacare-prior-authorization-benchmarks-medical-benefit-drugs 2026-07-05T01:55:11.456Z monthly 0.5 https://novapharmanews.com/eu/news/repertoire-immune-medicines-rptr-1-201-phase-1-2-trial-advanced-solid-tumors 2026-07-06T18:20:29.222Z monthly 0.5 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-first-patient 2026-07-06T18:33:53.265Z monthly 0.5 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-europe 2026-07-06T11:53:08.794Z monthly 0.5 https://novapharmanews.com/eu/news/blinatumomab-pediatric-leukemia-safety-study-final-stage 2026-07-06T10:12:44.539Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-third-party-logistics-market-growth-502-billion-2034 2026-07-06T16:19:28.180Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-intermediates-market-57-billion-2035-generic-drugs 2026-07-04T16:10:02.723Z monthly 0.5 https://novapharmanews.com/us/news/ose-immunotherapeutics-tedopi-ovarian-cancer-asco-2026-presentation 2026-07-05T08:54:06.923Z monthly 0.5 https://novapharmanews.com/us/news/nectero-therapeutics-east-system-two-year-safety-data-abdominal-aortic-aneurysm 2026-07-06T11:23:54.471Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-oral-semaglutide-children-type-2-diabetes-pioneer-teens-trial 2026-07-05T22:59:05.322Z monthly 0.5 https://novapharmanews.com/us/news/greenwich-lifesciences-glsi-100-asco-2026-breast-cancer-immunotherapy 2026-07-06T14:02:59.518Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-nectin-4-adc-phase-iii-triple-negative-breast-cancer 2026-07-06T13:51:39.929Z monthly 0.5 https://novapharmanews.com/us/news/clearpoint-neuro-fda-clearance-velocity-alpha-surgical-drill-system 2026-07-06T05:18:19.242Z monthly 0.5 https://novapharmanews.com/us/news/vistagen-refisolone-fda-approval-menopause-hot-flashes-phase-2-trial 2026-07-05T04:33:23.268Z monthly 0.5 https://novapharmanews.com/us/news/avai-bio-fda-cellular-rejuvenation-trial-anti-aging-market-120-billion 2026-07-06T11:43:35.514Z monthly 0.5 https://novapharmanews.com/us/news/cipla-fda-approval-first-generic-ventolin-hfa-albuterol-sulfate 2026-07-06T04:14:04.783Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-chronic-spontaneous-urticaria-children-sanofi 2026-07-06T18:16:21.046Z monthly 0.5 https://novapharmanews.com/us/news/oncology-data-trends-2026-preview 2026-07-06T18:03:06.734Z monthly 0.5 https://novapharmanews.com/us/news/redi-2026-fda-regulatory-strategies-conference-preview 2026-07-06T13:05:33.554Z monthly 0.5 https://novapharmanews.com/us/news/bionj-biopartnering-conference-2026-preview 2026-07-06T04:56:09.705Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-boston-preview 2026-07-06T14:20:22.622Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-day-1-eu-takeaways 2026-07-06T16:28:56.644Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-ai-biotech-preview 2026-07-06T07:28:48.163Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-roundup 2026-07-05T22:24:29.879Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-cro-trends-outsourcing 2026-07-06T17:24:56.427Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-biotech-day-1-roundup 2026-07-06T13:34:17.042Z monthly 0.5 https://novapharmanews.com/apac/news/calluna-pharma-cal101-phase-2-enrollment-ipf-treatment 2026-07-06T16:08:15.222Z monthly 0.5 https://novapharmanews.com/apac/news/anixa-biosciences-lira-cel-car-t-ovarian-cancer-survival-data 2026-07-06T15:34:30.866Z monthly 0.5 https://novapharmanews.com/apac/news/hengrui-pharma-q1-2026-anti-pd-l1-tgf-beta-fusion-protein-approved-china 2026-07-05T19:49:45.847Z monthly 0.5 https://novapharmanews.com/apac/news/sonorous-neurovascular-fda-clearance-boscath-catheter-2026 2026-07-06T13:58:45.853Z monthly 0.5 https://novapharmanews.com/apac/news/alphamab-oncology-jskn016-trop2-her3-bispecific-adc-her2-negative-breast-cancer-asco-2026 2026-07-06T08:39:22.984Z monthly 0.5 https://novapharmanews.com/apac/news/rfid-technology-pharmaceutical-supply-chain-15-billion-2032 2026-07-06T09:02:30.603Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-south-korea-gmp-certification-bispecific-antibody-manufacturing 2026-07-06T08:01:02.880Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-therapeutic-sunscreen-regulatory-framework-2024 2026-07-06T10:16:31.411Z monthly 0.5 https://novapharmanews.com/eu/news/belite-bio-tinlarebant-nda-submission-stargardt-disease-phase-3-dragon-trial 2026-07-06T15:05:01.022Z monthly 0.5 https://novapharmanews.com/eu/news/abivax-obefazimod-phase-3-data-digestive-disease-week-2026 2026-07-06T15:53:20.225Z monthly 0.5 https://novapharmanews.com/eu/news/pet-service-holding-2025-annual-results-veterinary-regulatory-changes 2026-07-06T00:01:12.024Z monthly 0.5 https://novapharmanews.com/eu/news/femasys-femaseed-complete-fertility-solution-obgyn-acog-2026 2026-07-06T16:26:35.627Z monthly 0.5 https://novapharmanews.com/eu/news/mauna-kea-technologies-ce-mark-mdr-approval-european-expansion 2026-07-04T09:07:15.309Z monthly 0.5 https://novapharmanews.com/eu/news/pembrolizumab-lenvatinib-clear-cell-cancer-trial-results 2026-07-06T10:10:02.218Z monthly 0.5 https://novapharmanews.com/eu/news/roche-gazyva-fda-acceptance-lupus-treatment-phase-iii-allegory 2026-07-04T23:33:35.089Z monthly 0.5 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-eu-approval-pediatric-brain-cancer-braf 2026-07-06T15:01:42.164Z monthly 0.5 https://novapharmanews.com/us/news/alterity-ath434-multiple-system-atrophy-phase-2-results 2026-07-06T09:41:53.542Z monthly 0.5 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-manufacturing-milestone-2026 2026-07-05T15:44:34.473Z monthly 0.5 https://novapharmanews.com/us/news/phanes-therapeutics-spevatamig-phase-2-results-pancreatic-cancer-asco-2026 2026-07-06T18:37:29.611Z monthly 0.5 https://novapharmanews.com/us/news/netris-pharma-np137-pancreatic-cancer-phase-1b-nature-results 2026-07-06T10:10:42.532Z monthly 0.5 https://novapharmanews.com/us/news/neurosterix-ntx-253-phase-1-schizophrenia-trial-q2-2026 2026-07-06T10:47:49.292Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-toripalimab-asco-2026-urothelial-carcinoma 2026-07-06T14:44:23.036Z monthly 0.5 https://novapharmanews.com/us/news/fda-complete-response-letter-atara-biotherapeutics-ebvallo-tabelecleucel-securities-lawsuit 2026-07-06T13:34:37.293Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-securities-lawsuit-fda-warning-letter-cancer-claims 2026-07-06T13:42:36.640Z monthly 0.5 https://novapharmanews.com/us/news/labcorp-fda-approved-pd-l1-companion-diagnostic-keytruda-ovarian-cancer 2026-07-06T02:40:47.261Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-children-chronic-spontaneous-urticaria-csu 2026-07-06T16:42:33.795Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-daily-roundup 2026-07-06T15:12:38.565Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-highlights 2026-07-06T01:58:52.762Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-news-today-opioid-crisis-drug-pricing-supply-chain 2026-07-06T11:52:27.537Z monthly 0.5 https://novapharmanews.com/eu/news/fda-idvynso-ascentage-asco-2026 2026-07-04T21:08:54.499Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-oncology-highlights 2026-07-06T16:20:46.906Z monthly 0.5 https://novapharmanews.com/apac/news/kelun-biotech-sacituzumab-tirumotecan-asco-2026-presentations 2026-07-06T17:00:58.626Z monthly 0.5 https://novapharmanews.com/apac/news/novi-health-glp-1-hybrid-care-model-clinical-real-world-gap 2026-07-05T17:44:49.848Z monthly 0.5 https://novapharmanews.com/apac/news/duchesnay-peripharm-regulatory-reform-womens-health-access-canada 2026-07-05T22:46:36.506Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-updates-ivd-regulations-medical-device-manufacturers 2026-07-06T15:08:20.668Z monthly 0.5 https://novapharmanews.com/apac/news/washington-state-life-sciences-industry-growth-2024 2026-07-06T16:37:44.717Z monthly 0.5 https://novapharmanews.com/eu/news/redhill-opaganib-neuroblastoma-breast-cancer-aacr-2026 2026-07-06T16:45:52.554Z monthly 0.5 https://novapharmanews.com/eu/news/sab-biotherapeutics-sab-142-c-peptide-preservation-type-1-diabetes-phase-1-trial 2026-07-05T18:13:33.930Z monthly 0.5 https://novapharmanews.com/eu/news/boston-scientific-q1-2026-earnings-clinical-trial-results 2026-07-06T14:46:28.741Z monthly 0.5 https://novapharmanews.com/eu/news/cervomed-neflamapimod-brain-volume-increase-dementia-lewy-bodies-aan-2026 2026-07-06T12:43:05.523Z monthly 0.5 https://novapharmanews.com/eu/news/celerion-thl-partners-majority-investment-clinical-research 2026-07-06T17:19:23.247Z monthly 0.5 https://novapharmanews.com/eu/news/veristat-acquires-certara-regulatory-writing-business-european-expansion 2026-07-06T12:30:44.198Z monthly 0.5 https://novapharmanews.com/eu/news/lung-cancer-therapeutics-market-142-billion-precision-medicine-2036 2026-07-05T16:54:38.867Z monthly 0.5 https://novapharmanews.com/eu/news/drug-delivery-devices-market-growth-forecast-2032-biologics 2026-07-06T03:55:28.264Z monthly 0.5 https://novapharmanews.com/eu/news/polycythemia-vera-market-transformation-protagonist-therapeutics-rusfertide-2036 2026-07-06T02:51:21.889Z monthly 0.5 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-first-targeted-therapy-pediatric-brain-tumors-eu-approval 2026-07-06T16:23:18.449Z monthly 0.5 https://novapharmanews.com/us/news/denali-therapeutics-fda-approval-avlayah-tividenofusp-alfa-hunter-syndrome 2026-07-06T12:59:16.631Z monthly 0.5 https://novapharmanews.com/us/news/pfizer-lorbrena-braftovi-asco-2026-cancer-trials 2026-07-06T18:35:25.371Z monthly 0.5 https://novapharmanews.com/us/news/boston-scientific-q1-2026-earnings-results-revenue-growth 2026-07-06T17:11:01.910Z monthly 0.5 https://novapharmanews.com/us/news/ractigen-rag-17-als-phase-1-trial-results-2026 2026-07-06T15:45:58.463Z monthly 0.5 https://novapharmanews.com/us/news/avacta-ava6103-cancer-drug-aacr-2026-data-enhertu-comparison 2026-07-05T22:28:29.654Z monthly 0.5 https://novapharmanews.com/us/news/innovent-ibi363-clinical-data-asco-2026 2026-07-05T21:45:27.225Z monthly 0.5 https://novapharmanews.com/us/news/fda-extends-sanofi-sarclisa-subcutaneous-review-multiple-myeloma 2026-07-06T10:48:51.479Z monthly 0.5 https://novapharmanews.com/us/news/nrx-pharmaceuticals-fda-feedback-preservative-free-ketamine-generic 2026-07-06T16:28:35.339Z monthly 0.5 https://novapharmanews.com/us/news/lupin-launches-generic-dapagliflozin-metformin-xr-tablets-us-xigduo-alternative 2026-07-03T08:16:36.980Z monthly 0.5 https://novapharmanews.com/us/news/sanofi-tzield-fda-approval-children-type-1-diabetes-delay 2026-07-06T18:00:22.007Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-sanofi-tzield-children-type-1-diabetes-delay 2026-07-06T14:27:44.958Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-day-1-roundup 2026-07-06T16:06:21.464Z monthly 0.5 https://novapharmanews.com/us/news/generic-drug-forum-us-market-access 2026-07-06T17:42:10.027Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-biotech-innovations-day-1 2026-07-06T15:04:38.760Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-daily-oncology-research-roundup 2026-06-30T20:12:11.347Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-news-purdue-sentencing-supply-chain-asco 2026-07-06T17:07:17.445Z monthly 0.5 https://novapharmanews.com/us/news/generic-drugs-forum-2026-fda-event-opens 2026-07-06T17:42:09.981Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-avantor-biolife-aes-highlights 2026-07-06T14:06:00.617Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-oncology-news-day-1 2026-07-06T04:07:55.371Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-oncology-research-highlights-day-1 2026-07-06T18:15:20.404Z monthly 0.5 https://novapharmanews.com/eu/news/slas-europe-2026-lab-automation-screening 2026-07-06T16:48:07.657Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-partnering-eu-2026-biotech-bdl-preview 2026-07-06T11:14:16.458Z monthly 0.5 https://novapharmanews.com/us/news/fda-redi-conference-2026-preview 2026-06-15T19:57:27.503Z monthly 0.5 https://novapharmanews.com/us/news/scopex-2026-causal-ai-ml-clinical-trials-preview 2026-07-06T18:29:26.380Z monthly 0.5 https://novapharmanews.com/us/news/pharma-manufacturing-innovation-us-2026 2026-07-05T22:41:23.543Z monthly 0.5 https://novapharmanews.com/eu/news/eu-pharma-innovation-trends-2026 2026-07-06T16:08:22.934Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-heor-preview 2026-07-06T14:55:32.907Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-2026-biotech-preview 2026-07-05T12:50:06.358Z monthly 0.5 https://novapharmanews.com/us/news/bio-it-world-2026-ai-oncology-preview 2026-07-06T17:24:46.275Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-heor-policy-pharma-pricing 2026-07-06T12:40:46.248Z monthly 0.5 https://novapharmanews.com/us/news/2nd-annual-cog-2026-pharma-preview 2026-07-06T04:26:59.206Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-preview 2026-07-05T23:10:54.076Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-calidi-biotherapeutics-redtail-preview 2026-07-06T07:04:34.148Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-trends-2026 2026-07-06T14:42:42.985Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-cell-gene-therapy-manufacturing-dublin 2026-07-06T18:23:44.934Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-preview 2026-07-06T18:23:39.312Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-preview 2026-07-06T07:13:12.705Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-2026-pharma-exec-networking 2026-07-06T12:31:25.311Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-2026-pharma-insights 2026-07-06T15:34:32.750Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-eu-mdr-regulatory-tech 2026-07-06T08:57:04.308Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-clinical-trial-tech 2026-07-05T20:30:51.251Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-preview 2026-07-05T19:03:00.667Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-preview 2026-07-06T06:13:04.857Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-2026-preview 2026-07-06T15:14:33.561Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-oncology-asco-aua 2026-07-06T13:17:30.316Z monthly 0.5 https://novapharmanews.com/us/news/4th-annual-cog-preview 2026-07-06T14:23:39.930Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-apac-biotech-preview 2026-07-06T17:17:09.779Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-preview 2026-07-06T02:16:17.771Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-pembrolizumab-bowel-cancer-moderna-melanoma 2026-07-06T12:11:46.528Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-day3-immunotherapy-kras-mrna 2026-07-06T08:57:37.912Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-preview 2026-07-06T17:41:13.635Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-2024-preview-eu 2026-07-06T09:11:16.253Z monthly 0.5 https://novapharmanews.com/apac/news/suvoda-agentic-ai-rtsm-clinical-trial-startup-reduction 2026-07-06T02:58:53.445Z monthly 0.5 https://novapharmanews.com/apac/news/dayspring-pharma-cg2001-foam-phase-ii-trial-androgenetic-alopecia-results 2026-07-05T04:14:10.363Z monthly 0.5 https://novapharmanews.com/apac/news/myome-board-appointments-healthcare-leaders-ai-genomics 2026-07-05T05:19:40.595Z monthly 0.5 https://novapharmanews.com/apac/news/synbiotech-l-plantarum-fs4722-hyperuricemia-prevention-preclinical 2026-07-06T09:06:28.020Z monthly 0.5 https://novapharmanews.com/apac/news/nasal-sprays-market-29-billion-2036-allergy-growth 2026-07-06T09:17:49.314Z monthly 0.5 https://novapharmanews.com/apac/news/andelyn-biosciences-encell-gene-therapy-manufacturing-partnership 2026-07-06T10:59:53.630Z monthly 0.5 https://novapharmanews.com/apac/news/turbine-crown-bioscience-ai-organoid-cancer-drug-discovery-partnership 2026-07-06T06:21:59.745Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-medicinal-cannabis-pediatric-access-guidelines-2024 2026-07-04T23:27:01.371Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-unapproved-therapeutic-goods-special-access-scheme-guidance 2026-07-06T14:11:59.386Z monthly 0.5 https://novapharmanews.com/apac/news/ghit-fund-8-5-million-malaria-ntd-drug-development-gsk-eisai 2026-07-06T12:29:06.828Z monthly 0.5 https://novapharmanews.com/eu/news/kelun-biotech-sac-tmt-asco-2026-presentations 2026-07-06T17:28:13.992Z monthly 0.5 https://novapharmanews.com/eu/news/prescriberpoint-ai-prior-authorization-platform-clinician-acceptance-rate 2026-07-01T20:03:45.971Z monthly 0.5 https://novapharmanews.com/eu/news/grail-galleri-cancer-detection-asco-2026-results 2026-07-06T16:29:54.455Z monthly 0.5 https://novapharmanews.com/eu/news/eupraxia-pharmaceuticals-positive-resolve-trial-eosinophilic-esophagitis-data 2026-07-06T13:07:21.628Z monthly 0.5 https://novapharmanews.com/eu/news/cellcarta-regask-ai-platform-regulatory-compliance-efficiency 2026-07-04T19:38:31.122Z monthly 0.5 https://novapharmanews.com/eu/news/leerink-partners-medincell-outperform-uzedy-risperidone-lai-fda-approval 2026-07-06T07:39:58.875Z monthly 0.5 https://novapharmanews.com/eu/news/getinge-cardiohelp-ii-ce-mark-intergard-synergy-eu-mdr-approval 2026-07-06T06:34:43.739Z monthly 0.5 https://novapharmanews.com/eu/news/karyopharm-phase-3-sentry-trial-asco-2026-myelofibrosis 2026-07-06T12:59:36.125Z monthly 0.5 https://novapharmanews.com/eu/news/allogene-therapeutics-expands-cemacabtagene-ansegedleucel-alpha3-trial-south-korea-australia 2026-07-05T06:42:50.822Z monthly 0.5 https://novapharmanews.com/eu/news/biocon-health-canada-approval-denosumab-biosimilars-bosaya-vevzuo 2026-07-06T15:17:05.323Z monthly 0.5 https://novapharmanews.com/us/news/francis-medical-vanquish-prostate-ablation-midwest-first-procedure 2026-07-06T07:51:51.866Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-anaphylm-fda-deficiencies-class-action-lawsuit 2026-07-05T06:11:15.779Z monthly 0.5 https://novapharmanews.com/us/news/efemoral-medical-bioresorbable-scaffold-97-percent-patency-peripheral-artery-disease 2026-07-05T22:15:01.772Z monthly 0.5 https://novapharmanews.com/us/news/kyverna-miv-cel-stiff-person-syndrome-trial-results-breakthrough 2026-07-06T03:03:00.406Z monthly 0.5 https://novapharmanews.com/us/news/invera-medical-90-percent-vein-closure-chronic-venous-disease-trial-results 2026-07-04T05:08:04.921Z monthly 0.5 https://novapharmanews.com/us/news/reva-medical-motiv-scaffold-superior-results-critical-limb-ischemia-trial 2026-07-06T14:27:03.266Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-nectin-4-adc-bulumtatug-fuvedotin-cervical-cancer-nejm-case-report 2026-07-06T05:09:50.293Z monthly 0.5 https://novapharmanews.com/us/news/outlook-therapeutics-fda-dispute-resolution-lytenava-bevacizumab 2026-07-06T06:20:28.799Z monthly 0.5 https://novapharmanews.com/us/news/follicular-lymphoma-clinical-trials-45-companies-2026 2026-07-06T09:07:37.319Z monthly 0.5 https://novapharmanews.com/us/news/obsidian-therapeutics-obx-115-phase-2-melanoma-asco-2026 2026-07-06T11:05:33.337Z monthly 0.5 https://novapharmanews.com/us/news/icecure-medical-prosense-revenue-increases-30-percent-q1-2026 2026-07-05T17:15:47.197Z monthly 0.5 https://novapharmanews.com/us/news/nuvalent-neladalkib-alkove-1-trial-data-asco-2026-alk-positive-nsclc 2026-07-06T11:37:35.170Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-merck-idvynso-hiv-treatment-doravirine-islatravir 2026-07-06T08:49:20.963Z monthly 0.5 https://novapharmanews.com/apac/news/peptidream-asahi-kasei-ak1940-phase-1-clinical-trial 2026-07-06T15:27:19.894Z monthly 0.5 https://novapharmanews.com/apac/news/rznomics-rz-001-hepatocellular-carcinoma-trial-results-aacr-2026 2026-07-06T16:38:28.685Z monthly 0.5 https://novapharmanews.com/apac/news/biogen-acquires-felzartamab-tj-biopharma-china 2026-07-06T15:06:22.366Z monthly 0.5 https://novapharmanews.com/apac/news/argo-biopharma-bw-40202-phase-ii-trials-sirna-therapy 2026-07-06T18:12:50.996Z monthly 0.5 https://novapharmanews.com/apac/news/mabwell-bioscience-pics-gmp-inspection-denosumab-biosimilars-jordan 2026-07-05T15:01:14.442Z monthly 0.5 https://novapharmanews.com/apac/news/mabwell-t-mab-jordan-gmp-inspection-denosumab-biosimilars-approval 2026-07-05T08:04:21.159Z monthly 0.5 https://novapharmanews.com/apac/news/quality-executive-partners-vienni-virtuosi-india-pharmaceutical-training 2026-07-05T07:02:49.894Z monthly 0.5 https://novapharmanews.com/apac/news/synsmart-amporin-partnership-small-molecule-therapeutics-degenerative-diseases 2026-07-06T17:51:30.728Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-otc-medicine-registration-guidelines-update 2026-07-03T05:08:57.122Z monthly 0.5 https://novapharmanews.com/apac/news/methylphenidate-shortage-update-concerta-ritalin-rubifen-supply-2026 2026-07-01T07:38:07.838Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approves-peripheral-rotablator-pro-visual-ice-cryoablation-system-japan 2026-07-06T07:10:53.111Z monthly 0.5 https://novapharmanews.com/eu/news/cigna-healthcare-imuldosa-biosimilar-preferred-coverage-accord-biopharma 2026-07-03T07:43:39.807Z monthly 0.5 https://novapharmanews.com/eu/news/briacell-bria-ots-phase-3-breast-cancer-quality-life-aacr-2026 2026-07-06T13:08:30.720Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-isolators-market-782-billion-eu-gmp-annex-1 2026-07-06T13:06:17.551Z monthly 0.5 https://novapharmanews.com/eu/news/mabwell-pics-gmp-compliance-jordan-fda-biopharmaceutical-manufacturing 2026-07-06T00:54:37.973Z monthly 0.5 https://novapharmanews.com/eu/news/implantica-refluxstop-device-safety-study-602-patients-europe 2026-07-06T18:33:51.226Z monthly 0.5 https://novapharmanews.com/eu/news/askbio-ametefgene-parvec-phase-ii-parkinson-gene-therapy 2026-07-05T17:48:39.212Z monthly 0.5 https://novapharmanews.com/us/news/lenz-therapeutics-vizz-presbyopia-uk-mhra-approval-submission 2026-07-06T07:02:36.508Z monthly 0.5 https://novapharmanews.com/us/news/pasithea-pas-004-fda-rare-pediatric-disease-designation-nf1 2026-07-06T05:30:02.349Z monthly 0.5 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-safety-endpoint-alcohol-use-disorder-trial 2026-07-04T07:55:39.975Z monthly 0.5 https://novapharmanews.com/us/news/sapience-therapeutics-st316-phase-2-colorectal-cancer-results 2026-07-06T06:49:48.859Z monthly 0.5 https://novapharmanews.com/us/news/tozorakimab-phase-3-miranda-trial-copd-exacerbations-reduction 2026-07-06T09:16:52.376Z monthly 0.5 https://novapharmanews.com/us/news/abogen-abo2203-mrna-cancer-therapy-b-cell-lymphoma-trial-aacr-2026 2026-07-03T20:41:31.159Z monthly 0.5 https://novapharmanews.com/us/news/verismo-synkir-110-phase-1-trial-results-aacr-2026 2026-07-06T15:44:07.359Z monthly 0.5 https://novapharmanews.com/us/news/inhibrx-ozekibart-inbrx-109-colorectal-cancer-clinical-update-webcast 2026-07-05T02:59:48.079Z monthly 0.5 https://novapharmanews.com/us/news/akeso-cadonilimab-pancreatic-cancer-phase-2-trial-results 2026-07-06T13:14:55.180Z monthly 0.5 https://novapharmanews.com/us/news/debiopharm-lunresertib-fda-fast-track-ovarian-cancer 2026-07-06T11:26:55.782Z monthly 0.5 https://novapharmanews.com/us/news/adcendo-adce-t02-expansion-phase-adce-d01-fda-orphan-drug-designation 2026-07-05T12:36:11.782Z monthly 0.5 https://novapharmanews.com/us/news/fda-accepts-genentech-gazyva-lupus-treatment-application 2026-07-06T15:25:43.236Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-padcev-keytruda-bladder-cancer-astellas 2026-07-06T06:24:38.930Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-dermaclear-severe-acne-2026 2026-07-04T21:36:33.698Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cell-therapy-multiple-sclerosis-2024 2026-07-06T16:09:15.639Z monthly 0.5 https://novapharmanews.com/us/news/fda-biosimilar-substitution-policy-update-2024 2026-07-06T12:40:48.861Z monthly 0.5 https://novapharmanews.com/eu/news/ema-biosimilar-policy-impact-2024 2026-07-06T01:07:59.290Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-paxlovid-covid19-treatment-eua-2024 2026-07-06T16:01:51.090Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-riabni-rituximab-biosimilar-nhl-2024 2026-07-06T13:37:10.984Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-adagrasib-kras-g12c-nsclc-2024 2026-07-06T15:47:40.330Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-apretude-injectable-prep-hiv-2024 2026-07-06T05:45:55.483Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-skin-renew-new-indication-severe-eczema-2024 2026-07-05T13:15:07.352Z monthly 0.5 https://novapharmanews.com/us/news/fda-update-diabetes-therapy-label-warning-2024 2026-07-06T16:37:13.673Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-genopharm-geno-cure-targeted-cancer-2024 2026-06-28T09:30:37.184Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-allerclear-otc-seasonal-allergies-2024 2026-07-06T15:26:03.905Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bact-away-antibiotic-resistant-infections-2024 2026-07-06T15:59:33.261Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-algorithma-algo-1-trd-2024 2026-07-06T18:29:36.550Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-trial-update-semaglutide-obesity-2024 2026-07-06T13:23:51.364Z monthly 0.5 https://novapharmanews.com/apac/news/alamar-biosciences-nasdaq-ipo-precision-proteomics-debut 2026-07-06T17:47:25.201Z monthly 0.5 https://novapharmanews.com/apac/news/act-genomics-101-gene-panel-cancer-testing-upgrade-2026 2026-07-05T23:26:59.880Z monthly 0.5 https://novapharmanews.com/apac/news/qdenga-dengue-vaccine-approved-australia-tga-four-serotypes 2026-07-06T15:55:24.039Z monthly 0.5 https://novapharmanews.com/eu/news/ema-iris-psur-submission-requirements-september-2025 2026-07-06T15:41:25.846Z monthly 0.5 https://novapharmanews.com/us/news/revolution-medicines-zoldonrasib-phase-1-data-kras-g12d-lung-cancer-aacr-2026 2026-07-06T18:27:14.645Z monthly 0.5 https://novapharmanews.com/us/news/epibiologics-epi-326-phase-1-trial-egfr-cancer 2026-07-06T07:28:34.986Z monthly 0.5 https://novapharmanews.com/us/news/sbc-medical-group-secondary-offering-3-1-million-shares 2026-07-05T10:05:54.872Z monthly 0.5 https://novapharmanews.com/us/news/fda-terminates-gas-delivery-engine-ventilator-recall-16650a 2026-07-06T16:42:11.601Z monthly 0.5 https://novapharmanews.com/us/news/philip-morris-iqos-fda-reauthorization-modified-risk-tobacco-product 2026-07-06T18:08:49.710Z monthly 0.5 https://novapharmanews.com/us/news/ascentage-pharma-preclinical-cancer-studies-aacr-2026 2026-07-06T02:00:11.153Z monthly 0.5 https://novapharmanews.com/us/news/whitehawk-therapeutics-hwk-007-adc-data-aacr-2026 2026-07-06T13:30:16.298Z monthly 0.5 https://novapharmanews.com/us/news/pulnovo-medical-100-million-medtronic-investment-pulmonary-hypertension 2026-07-06T17:23:50.024Z monthly 0.5 https://novapharmanews.com/us/news/nuance-pharma-ohtuvayre-enhance-china-phase-3-copd-results-chest-journal 2026-07-06T13:35:15.902Z monthly 0.5 https://novapharmanews.com/us/news/lundbeck-vyepti-migraine-cognitive-symptoms-infuse-study-2026 2026-07-06T16:38:53.828Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-biosimilar-clone-remicade-2026 2026-07-05T04:56:43.619Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-arterioflow-pad-2024 2026-07-06T11:17:11.334Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-v-protect-vaccine-2026 2026-07-06T08:36:02.635Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-inno-med-inhaler-tech-asthma-2024 2026-07-05T10:58:55.868Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-duo-boost-type-2-diabetes-2024 2026-07-06T14:18:53.592Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-rgen-101-raregen-orphan-drug-2024 2026-07-06T14:30:25.958Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-inflammex-ulcerative-colitis-2026 2026-07-06T14:23:01.610Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-synapton-alzheimers-2026 2026-07-06T18:00:04.381Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-generic-epipen-mylan-2024 2026-07-05T08:05:51.001Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-prevnar-20-pediatric-indication-2024 2026-07-05T22:07:19.947Z monthly 0.5 https://novapharmanews.com/apac/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-diseases 2026-07-06T18:13:55.946Z monthly 0.5 https://novapharmanews.com/apac/news/antengene-novel-cancer-programs-aacr-2026-adc-tce-therapies 2026-07-06T10:08:38.076Z monthly 0.5 https://novapharmanews.com/apac/news/antengene-adc-antengager-tce-programs-aacr-2026 2026-07-06T08:52:19.645Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-therapeutic-vaping-pharmacy-access-regulatory-framework 2026-07-06T10:05:41.833Z monthly 0.5 https://novapharmanews.com/apac/news/tga-medical-device-regulations-ai-software-therapeutic-products-australia 2026-07-06T10:52:06.885Z monthly 0.5 https://novapharmanews.com/eu/news/adagene-muzastotug-triple-combination-therapy-hepatocellular-carcinoma-aacr-2026 2026-07-06T08:40:14.280Z monthly 0.5 https://novapharmanews.com/eu/news/hytn-innovations-hard-cannabis-remediation-technology-gmp-processing-germany 2026-07-05T15:52:21.586Z monthly 0.5 https://novapharmanews.com/eu/news/sanofi-nuvaxovid-covid-vaccine-better-tolerability-mnexspike-phase-4-study 2026-07-05T03:36:10.500Z monthly 0.5 https://novapharmanews.com/eu/news/brand-institute-ema-approval-ai-pharmaceutical-branding-brandi-platform 2026-07-06T05:10:31.579Z monthly 0.5 https://novapharmanews.com/eu/news/ema-drug-patent-cliff-2026-european-exclusivities-expire 2026-07-06T11:55:31.516Z monthly 0.5 https://novapharmanews.com/eu/news/ema-chmp-recommends-six-new-medicines-approval-february-2024 2026-07-06T15:59:04.011Z monthly 0.5 https://novapharmanews.com/eu/news/ema-recommends-adstiladrin-gene-therapy-bladder-cancer-march-2026 2026-07-06T14:06:39.664Z monthly 0.5 https://novapharmanews.com/us/news/health-canada-approves-bracco-vueway-gadopiclenol-mri-contrast 2026-07-06T13:19:57.096Z monthly 0.5 https://novapharmanews.com/us/news/salubris-jk06-phase-1-2-cancer-trial-aacr-2024 2026-07-05T17:08:33.828Z monthly 0.5 https://novapharmanews.com/us/news/innate-pharma-iph5201-matisse-phase-2-aacr-2026-plenary-session 2026-07-06T16:26:54.965Z monthly 0.5 https://novapharmanews.com/us/news/accent-therapeutics-atx-295-kif18a-inhibitor-aacr-2026-cancer-data 2026-07-04T16:44:38.979Z monthly 0.5 https://novapharmanews.com/us/news/fda-reauthorizes-philip-morris-iqos-modified-risk-tobacco-product 2026-07-06T18:08:49.710Z monthly 0.5 https://novapharmanews.com/us/news/olema-oncology-palazestrant-op-3136-preclinical-data-aacr-2026 2026-07-06T15:52:56.520Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-neurona-therapeutics-nrtx-1001-epilepsy-cell-therapy 2026-07-06T18:30:47.318Z monthly 0.5 https://novapharmanews.com/us/news/xodus-medical-fda-clearance-hot-pink-pad-surgical-temperature-management 2026-07-06T17:24:44.868Z monthly 0.5 https://novapharmanews.com/us/news/argenx-vyvgart-myasthenia-gravis-cidp-aan-2026-clinical-data 2026-07-06T11:54:28.225Z monthly 0.5 https://novapharmanews.com/us/news/nuvalent-zidesamtinib-ros1-lung-cancer-aacr-2026 2026-07-06T13:47:30.763Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-verapamil-extended-release-hypertension-2024 2026-07-05T20:11:55.073Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-imgn-901-breakthrough-therapy-aml-2026 2026-07-06T06:02:04.923Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-revitan-gene-therapy-sma-type-3-2026 2026-07-06T14:27:09.880Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mito-x-accelerated-approval-2024 2026-07-03T02:47:57.601Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-xylocor-refractory-angina-2026 2026-07-06T14:36:44.826Z monthly 0.5 https://novapharmanews.com/apac/news/atara-biotherapeutics-class-action-lawsuit-atra-stockholders-losses 2026-07-06T06:29:19.542Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-hanmi-hmpl-523-alzheimer-herbal-medicine 2026-07-05T23:12:01.823Z monthly 0.5 https://novapharmanews.com/eu/news/gene-therapy-market-growth-crispr-aav-technologies-2034 2026-07-04T18:42:02.271Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-cold-chain-logistics-market-growth-2034-biopharmaceuticals-asia-pacific 2026-07-06T00:04:44.882Z monthly 0.5 https://novapharmanews.com/eu/news/aim-immunotech-ampligen-phase-3-pancreatic-cancer-trial-orphan-drug 2026-07-06T12:20:09.183Z monthly 0.5 https://novapharmanews.com/eu/news/ab-science-masitinib-als-phase-3-trial-insurance-25-million 2026-07-06T10:12:50.800Z monthly 0.5 https://novapharmanews.com/eu/news/meiragTx-acquires-botaretigene-sparoparvovec-gene-therapy-xlrp-johnson-johnson 2026-07-06T17:23:42.435Z monthly 0.5 https://novapharmanews.com/eu/news/beamion-zongertinib-fda-approval-her2-mutant-nsclc-lung-1-study 2026-07-06T07:47:55.767Z monthly 0.5 https://novapharmanews.com/eu/news/tri-611-fda-fast-track-alk-positive-nsclc-eisai-taletrectinib 2026-07-05T11:30:52.846Z monthly 0.5 https://novapharmanews.com/us/news/maia-biotechnology-phase-2-nsclc-telomere-treatment-trial-us-site 2026-07-06T06:24:57.104Z monthly 0.5 https://novapharmanews.com/us/news/dr-falk-pharma-renexxion-naronapride-phase-2b-gastroparesis-ddw-2026 2026-07-04T23:35:51.274Z monthly 0.5 https://novapharmanews.com/us/news/lilly-foundayo-orforglipron-achieve-4-trial-results-mortality-reduction 2026-07-06T04:54:30.553Z monthly 0.5 https://novapharmanews.com/us/news/aicuris-pritelivir-fda-priority-review-herpes-treatment 2026-07-06T15:18:26.955Z monthly 0.5 https://novapharmanews.com/us/news/medera-aav-serca2a-fda-fast-track-duchenne-cardiomyopathy 2026-07-05T23:13:40.271Z monthly 0.5 https://novapharmanews.com/us/news/boehringer-ingelheim-zongertinib-her2-mutant-lung-cancer-nejm-study 2026-07-05T20:29:46.821Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mindbalance-digital-therapeutic-2026 2026-07-06T11:28:59.388Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cancervax-adjuvant-melanoma-2026 2026-07-06T06:02:49.506Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-painblock-patch-chronic-pain-2024 2026-07-06T17:21:16.799Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-renalprotect-expanded-use-dkd-2024 2026-07-03T13:22:54.464Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-lungrx-inhaled-therapy-pulmonary-hypertension-2026 2026-07-05T06:32:34.419Z monthly 0.5 https://novapharmanews.com/apac/news/sanyou-ai-stal-2-antibody-discovery-14-days-drug-development 2026-07-06T07:11:08.531Z monthly 0.5 https://novapharmanews.com/apac/news/gene-expression-analysis-market-593-billion-2031-drug-discovery 2026-07-05T17:04:30.971Z monthly 0.5 https://novapharmanews.com/apac/news/perceptive-discovery-mh3d-alpha-sight-radiopharmaceutical-imaging 2026-07-05T23:19:46.290Z monthly 0.5 https://novapharmanews.com/apac/news/pg-health-apac-pharmacist-guidelines-peripheral-neuropathy-management 2026-07-06T11:32:20.423Z monthly 0.5 https://novapharmanews.com/apac/news/tga-assessed-listed-medicines-framework-update-australia 2026-07-06T11:11:28.301Z monthly 0.5 https://novapharmanews.com/apac/news/corcept-therapeutics-relacorilant-fda-rejection-investor-lawsuit-2025 2026-07-06T14:28:28.559Z monthly 0.5 https://novapharmanews.com/apac/news/florida-cancer-specialists-medically-integrated-oncology-care-2024 2026-07-04T12:01:31.287Z monthly 0.5 https://novapharmanews.com/eu/news/traws-pharma-tivoxavir-marboxil-influenza-trial-ratutrelvir-covid-results-2025 2026-07-06T16:33:10.063Z monthly 0.5 https://novapharmanews.com/eu/news/tme-pharma-nox-a12-triple-therapy-brain-cancer-gloria-trial-nature-communications 2026-07-05T17:02:00.933Z monthly 0.5 https://novapharmanews.com/eu/news/additional-risk-minimization-measures-armms-training-course-patient-safety 2026-07-05T14:21:52.068Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-logistics-market-growth-159-billion-2030-biopharmaceutical-cold-chain 2026-07-06T13:10:24.952Z monthly 0.5 https://novapharmanews.com/eu/news/medical-device-software-compliance-training-eu-mdr-ivdr-fda-june-2026 2026-07-06T08:09:33.463Z monthly 0.5 https://novapharmanews.com/eu/news/onward-medical-40-million-capital-increase-eqt-life-sciences 2026-07-06T12:48:07.102Z monthly 0.5 https://novapharmanews.com/eu/news/sahpra-african-medicines-agency-regulatory-harmonization-course-may-2026 2026-07-06T11:01:37.475Z monthly 0.5 https://novapharmanews.com/eu/news/bavarian-nordic-vimkunya-chikungunya-vaccine-swiss-approval-swissmedic 2026-07-06T01:21:56.516Z monthly 0.5 https://novapharmanews.com/eu/news/seragon-srn-901-longevity-drug-lifespan-extension-preclinical-study 2026-07-05T22:35:36.473Z monthly 0.5 https://novapharmanews.com/us/news/fda-food-additive-contact-substance-regulatory-updates-2026 2026-07-06T13:46:08.545Z monthly 0.5 https://novapharmanews.com/us/news/recognition-health-alzheimers-blood-test-clinical-trial-2026 2026-07-06T12:45:18.187Z monthly 0.5 https://novapharmanews.com/us/news/sedogen-diazoxide-patent-prader-willi-syndrome-behavioral-symptoms 2026-07-05T15:40:27.143Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-lilrb4-cd3-bispecific-antibody-6mw5311-nmpa-ind-approval-leukemia 2026-07-06T18:18:46.420Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-maiweijian-denosumab-nmpa-acceptance-cancer-bone-treatment 2026-07-06T06:49:32.438Z monthly 0.5 https://novapharmanews.com/us/news/thinktrends-ai-federal-health-agency-adverse-event-monitoring-system 2026-07-05T18:09:23.875Z monthly 0.5 https://novapharmanews.com/us/news/fullscript-journeys-digital-health-platform-launch-2024 2026-07-06T18:15:10.263Z monthly 0.5 https://novapharmanews.com/us/news/nexalin-technology-fda-alzheimers-strategy-meetings-china-us 2026-07-04T16:44:18.661Z monthly 0.5 https://novapharmanews.com/us/news/fda-warning-letters-pharmaceutical-compliance-drug-safety-2024 2026-07-06T15:32:11.773Z monthly 0.5 https://novapharmanews.com/us/news/gsk-depemokimab-european-chinese-approval-ultra-long-acting-biologic 2026-07-06T15:00:58.896Z monthly 0.5 https://novapharmanews.com/us/news/elion-therapeutics-turletricin-phase-2-trial-invasive-mold-infections 2026-07-06T17:16:13.566Z monthly 0.5 https://novapharmanews.com/us/news/glaukos-epioxa-permanent-j-code-j2789-cms-approval 2026-07-06T13:06:10.006Z monthly 0.5 https://novapharmanews.com/us/news/nkarta-fda-approval-outpatient-nkx019-dosing-autoimmune-disease 2026-07-05T17:17:25.647Z monthly 0.5 https://novapharmanews.com/apac/news/phantom-neuro-phantom-x-first-human-trial-approval-australia 2026-07-05T03:37:40.619Z monthly 0.5 https://novapharmanews.com/eu/news/boehringer-ingelheim-zai-lab-dll3-targeting-combination-therapy-small-cell-lung-cancer-trial 2026-07-06T13:09:29.123Z monthly 0.5 https://novapharmanews.com/eu/news/imvt-1402-myasthenia-gravis-treatment-pipeline-2026 2026-07-06T12:56:57.909Z monthly 0.5 https://novapharmanews.com/us/news/dogwood-therapeutics-sp16-fda-ind-approval-chemotherapy-pain 2026-07-06T17:32:43.232Z monthly 0.5 https://novapharmanews.com/us/news/pds-biotech-pds01adc-78-percent-response-rate-colorectal-cancer-phase-2 2026-07-04T13:42:53.564Z monthly 0.5 https://novapharmanews.com/us/news/neffy-epinephrine-nasal-spray-approved-canada-needle-free-anaphylaxis-treatment 2026-07-06T15:25:09.138Z monthly 0.5 https://novapharmanews.com/us/news/cala-fda-clearance-kiq-plus-wearable-device-essential-tremor-parkinsons 2026-07-06T17:28:24.149Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-rapiblyk-landiolol-pediatric-svt-aop-health 2026-07-04T11:21:46.427Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-gi-innovation-gi-101a-phase-1-data-preview 2026-07-06T08:07:34.683Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-sleepwell-chronic-insomnia-2026 2026-07-06T12:37:39.899Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-nanopharm-metastatic-breast-cancer-2024 2026-07-05T20:58:54.244Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-fluguard-novel-influenza-vaccine-2026 2026-07-04T15:59:08.392Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cardiodetect-ai-diagnostic-arrhythmia-2026 2026-07-06T12:29:43.322Z monthly 0.5 https://novapharmanews.com/apac/news/phrontline-biopharma-tj106-her2-adc-preclinical-data-aacr-2026 2026-07-06T13:15:42.147Z monthly 0.5 https://novapharmanews.com/apac/news/xellsmart-xs411-parkinsons-cell-therapy-phase-ii-trial-2026 2026-07-06T00:45:38.598Z monthly 0.5 https://novapharmanews.com/apac/news/peer-ai-regulatory-platform-predictive-intelligence-life-sciences 2026-07-06T05:54:18.425Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-iso-13485-certification-drug-device-combination-products 2026-07-06T08:45:07.221Z monthly 0.5 https://novapharmanews.com/apac/news/atelerix-jh-health-partnership-cell-preservation-middle-east 2026-07-06T09:29:38.673Z monthly 0.5 https://novapharmanews.com/apac/news/chitosan-market-growth-kitozyme-primex-pharmaceutical-biopolymer-2036 2026-07-06T17:58:15.250Z monthly 0.5 https://novapharmanews.com/apac/news/telix-tlx101-tx-phase-3-glioblastoma-trial-first-patient 2026-07-06T01:53:22.320Z monthly 0.5 https://novapharmanews.com/apac/news/nmn-500mg-energy-support-tga-approval-australia 2026-07-06T03:54:46.181Z monthly 0.5 https://novapharmanews.com/eu/news/drug-development-services-market-31-billion-2026-pharma-rd-investments 2026-07-05T06:53:31.975Z monthly 0.5 https://novapharmanews.com/eu/news/medicenna-bizaxofusp-brain-cancer-trials-2026-investor-conference 2026-07-06T12:02:56.132Z monthly 0.5 https://novapharmanews.com/eu/news/vitestro-autonomous-robotic-phlebotomy-device-clinical-trial-results 2026-07-06T07:24:00.206Z monthly 0.5 https://novapharmanews.com/eu/news/grace-therapeutics-gtx-104-phase-3-strive-on-trial-aan-2026 2026-07-06T13:31:07.005Z monthly 0.5 https://novapharmanews.com/eu/news/mena-medical-device-regulatory-training-course-may-2026 2026-07-06T17:46:59.913Z monthly 0.5 https://novapharmanews.com/eu/news/cmo-cdmo-market-growth-biologics-manufacturing-2035 2026-07-06T18:04:39.821Z monthly 0.5 https://novapharmanews.com/eu/news/clinical-trial-monitoring-gcp-compliance-course-2026 2026-07-06T18:04:49.962Z monthly 0.5 https://novapharmanews.com/eu/news/gcp-inspections-training-course-ich-e6-r3-eu-ctr-compliance-july-2026 2026-07-05T21:07:47.409Z monthly 0.5 https://novapharmanews.com/eu/news/vabysmo-market-report-2026-roche-eye-drug-growth-forecast 2026-07-06T07:29:56.387Z monthly 0.5 https://novapharmanews.com/eu/news/glyconex-gnx1021-pmda-approval-phase-1-trial-gastrointestinal-cancers 2026-07-06T14:26:30.774Z monthly 0.5 https://novapharmanews.com/us/news/psoriasis-clinical-trial-pipeline-90-companies-2026 2026-07-06T01:48:14.971Z monthly 0.5 https://novapharmanews.com/us/news/meiragTx-aav-haqp1-gene-therapy-xerostomia-3-year-data-april-2026 2026-07-06T10:54:59.411Z monthly 0.5 https://novapharmanews.com/us/news/corbus-pharmaceuticals-crb-913-obesity-drug-canyon-1-trial-enrollment-complete 2026-07-05T19:14:47.124Z monthly 0.5 https://novapharmanews.com/us/news/actuate-therapeutics-elraglusib-pancreatic-cancer-survival-nature-medicine 2026-07-06T16:56:33.292Z monthly 0.5 https://novapharmanews.com/us/news/dupont-amberchrom-xt-sl-chromatography-resins-biopharmaceutical-manufacturing 2026-07-06T10:44:35.646Z monthly 0.5 https://novapharmanews.com/us/news/vasa-therapeutics-lilly-tunelab-ai-camkii-inhibitor-partnership 2026-07-06T16:58:18.495Z monthly 0.5 https://novapharmanews.com/us/news/synusight-biotech-sst001-alpha-synuclein-pet-tracer-nmpa-approval-phase-1-trial 2026-07-06T09:12:09.093Z monthly 0.5 https://novapharmanews.com/us/news/oryon-cell-therapies-appoints-burkhard-blank-chief-medical-officer 2026-07-06T14:37:58.963Z monthly 0.5 https://novapharmanews.com/us/news/amneal-launches-albuterol-beclomethasone-respiratory-inhalers-2026 2026-07-06T12:12:59.668Z monthly 0.5 https://novapharmanews.com/us/news/bright-path-fy2027-budget-domestic-pharmaceutical-manufacturing 2026-07-06T09:42:31.777Z monthly 0.5 https://novapharmanews.com/us/news/partner-therapeutics-bizengri-fda-application-cholangiocarcinoma-nrg1-fusion 2026-07-06T12:20:21.812Z monthly 0.5 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-alcohol-use-disorder-trial-results 2026-07-04T07:41:56.101Z monthly 0.5 https://novapharmanews.com/us/news/praxis-precision-medicines-fda-accepts-ulixacaltamide-hcl-essential-tremor-nda 2026-07-06T18:27:00.918Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-filspari-sparsentan-fsgs-first-treatment-rare-kidney-disease 2026-07-06T12:24:10.942Z monthly 0.5 https://novapharmanews.com/us/news/apotex-fda-approval-generic-infuvite-adult-injection-exclusivity 2026-07-06T06:03:16.961Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-orphan-drug-rarecure-ert-2026 2026-07-06T07:19:00.236Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-migraease-new-migraine-drug-2024 2026-07-05T15:08:00.517Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-expanded-indication-elahere-2024 2026-07-05T14:57:35.163Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cardioshield-hfpef-2026 2026-07-06T14:47:58.329Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-vitacorp-antibiotic-priority-review-2024 2026-07-06T06:21:21.439Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-neurovance-xr-pediatric-adhd-2026 2026-07-06T05:00:56.668Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-lumagen-gene-therapy-2024 2026-07-06T14:33:33.972Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-biosimilar-insulin-lispro-biosolve-2026 2026-07-03T16:41:58.612Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-oncocure-trk-inhibitor-2024 2026-07-05T08:18:20.924Z monthly 0.5 https://novapharmanews.com/eu/news/ema-implement-ai-system-drug-safety-2024 2026-07-06T06:05:08.411Z monthly 0.5 https://novapharmanews.com/eu/news/european-commission-launches-blockchain-pilot-pharmaceutical-supply-chain-2024 2026-07-06T15:00:38.258Z monthly 0.5 https://novapharmanews.com/apac/news/nmepa-priority-review-ai-diagnostic-early-cancer-2024 2026-07-03T14:49:49.233Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approval-ai-platform-personalized-medicine-oncology-2024 2026-07-06T13:30:09.749Z monthly 0.5 https://novapharmanews.com/us/news/fda-launches-blockchain-pilot-program-pharmaceutical-supply-chain-2024 2026-07-06T09:01:34.792Z monthly 0.5 https://novapharmanews.com/us/news/fda-implement-ai-powered-expedited-drug-review-2027 2026-07-06T14:23:04.321Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-renoprotect-diabetic-kidney-disease-therapy-2024 2026-07-04T05:18:50.737Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-airflow-inhalable-severe-asthma-2026 2026-07-06T03:29:14.639Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-osteobuild-bone-building-agent-severe-osteoporosis-2026 2026-07-06T17:38:45.293Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-arterioflow-peripheral-artery-disease-2026 2026-07-06T13:15:08.912Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-cholesterolrx-high-cholesterol-2024 2026-07-06T11:33:17.106Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opti-sight-glaucoma-2026 2026-07-06T06:24:12.919Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-microbalance-crohns-disease-2026 2026-07-06T13:52:39.069Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-somnirestore-chronic-insomnia-2026 2026-07-06T15:34:03.558Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-neurobloc-non-opioid-pain-reliever-2026 2026-07-06T02:06:10.209Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lysoclear-lysosomal-storage-disorders-2026 2026-07-01T21:09:50.279Z monthly 0.5 https://novapharmanews.com/eu/news/ema-conditional-approval-car-t-relapsed-b-cell-lymphoma-2024 2026-07-06T16:08:29.955Z monthly 0.5 https://novapharmanews.com/us/news/fda-breakthrough-therapy-targtex-tx202-glioblastoma-2024 2026-07-06T02:09:38.630Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bria-cell-bria-imt-car-t-therapy-advanced-breast-cancer-2024 2026-07-06T06:38:30.940Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-zepzelca-lurbinectedin-cancer-treatment 2026-07-04T03:50:31.042Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-amgen-tarlatamab-imdylltra-small-cell-lung-cancer 2026-07-06T02:35:37.044Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-adstiladrin-gene-therapy-bladder-cancer 2026-07-06T14:06:39.663Z monthly 0.5 https://novapharmanews.com/eu/news/ema-recommends-imdylltra-tarlatamab-small-cell-lung-cancer-approval 2026-07-06T13:00:03.117Z monthly 0.5 https://novapharmanews.com/eu/news/ema-virtual-control-groups-reduce-animal-testing-drug-development 2026-07-06T07:47:49.750Z monthly 0.5 https://novapharmanews.com/us/news/fda-manufacturing-precheck-pilot-program-streamline-oversight 2026-07-06T08:59:58.702Z monthly 0.5 https://novapharmanews.com/us/news/real-world-evidence-transforms-drug-development-fda-regulatory-framework 2026-07-04T07:14:07.538Z monthly 0.5 https://novapharmanews.com/us/news/fda-untitled-letters-pharmaceutical-marketing-violations-database 2026-07-06T15:09:44.048Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-higher-dose-wegovy-7-2mg-weight-loss-priority-review 2026-07-05T11:27:17.427Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-avlayah-hunter-syndrome-neurologic-treatment 2026-07-05T07:53:20.515Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-kresladi-first-gene-therapy-lad-i-leukocyte-adhesion-deficiency 2026-07-06T10:25:46.260Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-foundayo-orforglipron-priority-voucher-program 2026-07-06T15:29:51.469Z monthly 0.5 https://novapharmanews.com/eu/news/ema-analysis-ai-pharma-rd-investment-2024 2026-07-06T17:40:08.526Z monthly 0.5 https://novapharmanews.com/eu/news/ema-accelerated-assessment-novel-mrna-vaccine-platforms-2024 2026-07-06T02:15:15.964Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approval-gene-therapies-neurological-disorders-2024 2026-07-05T01:43:47.645Z monthly 0.5 https://novapharmanews.com/eu/news/ema-clinical-trials-regulation-rare-disease-2026 2026-07-06T15:23:52.300Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-dermtech-skinguard-severe-eczema-2026 2026-07-04T11:50:49.114Z monthly 0.5 https://novapharmanews.com/eu/news/ema-blockchain-pharmaceutical-supply-chain-2024 2026-07-06T12:28:57.029Z monthly 0.5 https://novapharmanews.com/eu/news/ema-gdpr-impact-pharmaceutical-data-2024 2026-07-06T17:29:53.144Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-data-integrity-requirements-guide-2024 2026-07-06T15:03:03.894Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cognimax-alzheimers-2026 2026-07-06T18:17:02.647Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-vitarestrore-age-related-macular-degeneration-2026 2026-07-06T18:13:44.453Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-nasoclear-pediatric-rsv-2026 2026-07-06T18:17:24.581Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-revitalize-chronic-fatigue-syndrome-2026 2026-07-06T17:59:38.991Z monthly 0.5 https://novapharmanews.com/eu/news/ema-ai-powered-clinical-trial-matching-patient-recruitment-2024 2026-07-06T18:08:46.363Z monthly 0.5 https://novapharmanews.com/eu/news/ema-regulatory-outlook-digital-therapeutics-europe-2024 2026-07-06T18:10:02.674Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-ai-clinical-trial-matching-china-2024 2026-07-06T18:13:13.214Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-telemedicine-apac-opportunities-challenges-2024 2026-07-06T18:16:49.063Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-genecorrect-gene-therapy-cystic-fibrosis-2026 2026-07-06T18:06:45.649Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-myorepair-breakthrough-therapy-2026 2026-07-06T18:01:58.483Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-oncoblock-refractory-aml-2024 2026-07-06T18:01:35.078Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-xylocor-nda-advanced-melanoma-2024 2026-07-06T17:57:00.222Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-repatha-evolocumab-cardiovascular-prevention-2024 2026-07-06T18:01:44.034Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-tecentriq-atezolizumab-es-sclc-2024 2026-07-06T18:02:05.396Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-advanced-rcc-2024 2026-07-06T17:52:41.164Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-keytruda-adjuvant-stage-iii-melanoma-2024 2026-07-06T17:53:28.204Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-aduhelm-alzheimers-2021 2026-07-06T17:51:50.432Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-dupixent-eosinophilic-esophagitis-2024 2026-07-06T17:54:46.636Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-johnson-johnson-stelara-ulcerative-colitis-2024 2026-07-06T17:47:12.709Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-imfinzi-durvalumab-stage-iii-nsclc-2024 2026-07-06T17:50:20.979Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-trikafta-cystic-fibrosis-children-2024 2026-07-06T17:46:39.492Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mounjaro-weight-management-2024 2026-07-06T17:47:49.760Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cosentyx-hidradenitis-suppurativa-2024 2026-07-06T17:45:06.549Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-moderna-mrna-1345-rsv-vaccine-2024 2026-07-06T17:38:51.753Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-zithromax-pediatric-cap-2026 2026-07-06T17:43:14.029Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-revivcor-etanercept-biosimilar-heart-failure-2024 2026-07-06T17:39:33.665Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-breakthrough-innovent-kras-g12c-inhibitor-2024 2026-07-06T17:34:25.268Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-accepts-shionogi-influenza-drug-sakigake-2024 2026-07-06T17:34:20.556Z monthly 0.5 https://novapharmanews.com/apac/news/cdsco-policy-changes-generics-market-growth-india-2024 2026-07-06T17:35:39.658Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-sakigake-designation-regenerative-medicine-market-access-2024 2026-07-06T17:36:41.428Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-priority-review-pathway-innovative-drug-approvals-2024 2026-07-06T17:28:59.914Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-inhalex-copd-2026 2026-07-06T17:29:33.699Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-rapiclot-tranexamic-acid-trauma-2026 2026-07-06T17:28:13.235Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-tarzenta-advanced-her2-negative-breast-cancer-2024 2026-07-06T17:29:05.534Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-ritempro-parkinsons-2026 2026-07-06T17:23:23.605Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-expedited-review-novel-melanoma-therapies-2024 2026-07-06T17:21:11.665Z monthly 0.5 https://novapharmanews.com/apac/news/tga-innovation-report-australian-biotech-solid-tumor-car-t-2024 2026-07-06T17:21:07.912Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-tevimbra-tislelizumab-escc-2024 2026-07-06T18:16:57.134Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-wainua-eplontersen-hattr-pn-2024 2026-07-06T17:19:31.444Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-sanofi-altuviiio-hemophilia-a-2024 2026-07-06T17:17:50.396Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-augtyro-repotrectinib-ros1-nsclc-2024 2026-07-06T17:13:52.594Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-litfulo-ritlecitinib-alopecia-2024 2026-07-06T17:18:09.925Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-gmp-standards-foreign-manufacturers-impact-2024 2026-07-06T17:56:27.789Z monthly 0.5 https://novapharmanews.com/eu/news/mhra-vs-ema-regulatory-pathway-strategy-2024 2026-07-06T16:38:39.401Z monthly 0.5 https://novapharmanews.com/eu/news/ema-market-analysis-orphan-drug-pricing-reimbursement-2024 2026-07-06T16:57:46.882Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-accelerated-approval-orphan-drugs-impact-future-trends-2024 2026-07-06T16:57:48.840Z monthly 0.5 https://novapharmanews.com/apac/news/ich-guidelines-biosimilar-development-apac-2024 2026-07-06T17:13:05.930Z monthly 0.5 https://novapharmanews.com/apac/news/cdsco-forecasting-biosimilar-market-growth-india-2024 2026-07-06T17:14:30.838Z monthly 0.5 https://novapharmanews.com/apac/news/tga-pmda-uptake-adalimumab-biosimilars-2024 2026-07-06T17:10:31.079Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-biosimilar-framework-trastuzumab-adoption-2024 2026-07-06T17:09:37.893Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-biosimilar-approval-pathway-analysis-2024 2026-07-06T17:09:35.022Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-repatha-pediatric-hefh-2024 2026-07-06T17:06:33.030Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-adzynma-thrombotic-thrombocytopenic-purpura-2024 2026-07-06T17:05:09.297Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-otc-naloxone-nasal-spray-opioid-overdose-2024 2026-07-06T17:06:22.728Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-sotorasib-kras-g12c-nsclc-2024 2026-07-06T17:02:22.931Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-veozah-fezolinetant-menopause-2024 2026-07-06T17:10:28.513Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-pmda-tga-pompe-disease-market-analysis-2024 2026-07-06T17:00:57.582Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-omidubicel-onlv-2026 2026-07-06T16:56:53.702Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-updated-covid19-vaccines-fall-2024 2026-07-06T16:52:03.096Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bosulif-pediatric-cml-2024 2026-07-06T16:53:18.386Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-ztalmy-ganaxolone-cdkl5-deficiency-2024 2026-07-06T17:46:36.674Z monthly 0.5 https://novapharmanews.com/eu/news/ema-impact-eu-pharmaceutical-strategy-api-manufacturing-2024 2026-07-06T16:44:45.306Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-gastric-cancer-2024 2026-07-06T16:45:55.763Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-breyanzi-car-t-mantle-cell-lymphoma-2024 2026-07-06T18:09:52.678Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-mirvetuximab-soravtansine-elahere-2026 2026-07-06T16:42:36.071Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-elarek-osteoporosis-prevention-2026 2026-07-06T16:38:33.921Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-approval-bevacizumab-biosimilar-china-2024 2026-07-06T18:23:23.533Z monthly 0.5 https://novapharmanews.com/eu/news/ema-marketing-authorization-denosumab-biosimilar-2024 2026-07-06T16:32:40.298Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-interchangeable-biosimilar-ustekinumab-2024 2026-07-06T16:27:40.712Z monthly 0.5 https://novapharmanews.com/eu/news/chmp-positive-opinion-car-t-therapy-relapsed-b-cell-lymphoma-2024 2026-07-06T16:32:37.848Z monthly 0.5 https://novapharmanews.com/eu/news/ema-legislation-reform-biopharma-innovation-2024 2026-07-06T16:26:49.422Z monthly 0.5 https://novapharmanews.com/apac/news/tga-australia-early-phase-trials-analysis-2024 2026-07-06T18:13:28.439Z monthly 0.5 https://novapharmanews.com/eu/news/ema-artificial-intelligence-clinical-trials-guidelines-2024 2026-07-06T16:11:31.993Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-anti-inflammatory-atopic-dermatitis-2024 2026-07-06T16:11:39.415Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-amgen-bispecific-antibody-colorectal-cancer-2024 2026-07-06T16:08:57.427Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-syfovre-geographic-atrophy-2023 2026-07-06T16:09:25.062Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-endeavorrx-digital-therapeutic-adhd-2024 2026-07-06T16:18:34.902Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-roche-ntrk-fusion-therapy-2024 2026-07-06T16:02:17.298Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-casgevy-gene-therapy-sickle-cell-2023 2026-07-06T17:17:51.413Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-humira-biosimilar-interchangeable-2023 2026-07-06T15:58:22.902Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-gilead-hiv-bimonthly-treatment-2024 2026-07-06T17:30:17.579Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-astrazeneca-wilson-disease-2024 2026-07-06T16:00:25.819Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-donanemab-alzheimers-2024 2026-07-06T18:09:25.156Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-novartis-breast-cancer-treatment-2024 2026-07-06T15:32:09.486Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lumakras-nsclc-2023 2026-07-06T15:24:19.409Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-talquetamab-multiple-myeloma-2024 2026-07-06T15:52:59.224Z monthly 0.5